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Somatic Cell Nuclear Transfer (SCNT), commonly known as cloning, is the
transfer of a somatic nucleus into an enucleated oocyte to produce a clone. The chromatin
structure of somatic cells permits the expression of certain genes, while silencing the rest
of the genome. The cytoplasm of oocytes can reprogram a somatic nucleus by
reactivating the genes necessary for embryonic development and silencing the somatic
genes. However, the low efficiency of SCNT indicates that successful nuclear
reprogramming is a rare event. The objectives of this study were determine the extent of
transcriptional reprogramming in bovine blastocysts produced by serial rounds of
chromatin transfer (from first and fourth generations), using blastocysts produced by in
vitro fertilization (IVF) as controls, to identify cumulative errors in the transcriptome
profile. Differentially expressed genes were studied further to determine their function in
embryonic development. We identified a set of transcripts consistently misregulated in
iii

blastocysts produced be chromatin transfer (CT), some of which had a more marked
misregulation in the embryos produced by 4 successive rounds of cloning. Among the
genes significantly upregulated in both CT groups compared to IVF blastocysts were both
de novo DNA methylation enzymes DNMT3A and DNMT3B. Expression patterns,
structural and functional analyses were performed for DNA methyltransferases. A high
level of structural and functional conservation was observed for DNA methyltransferases
among human, mouse, and bovine species. A set of genes that participate in early
embryonic development, chromatin remodeling and DNA methylation were differentially
regulated in cloned embryos and had not been fully annotated at the time of the analysis.
We annotated those genes and submitted them to the Bovine Genome Sequencing
Consortium database. These results have important implications for the selection of
models for the study of DNA methylation during early development. The present study
provides a valuable data set for identifying possible cumulative errors in somatic cell
chromatin transfer that could hinder nuclear reprogramming, shedding light on the
epigenetic role in reprogramming and cell plasticity.

Key Words: nuclear reprogramming, embryonic transcriptome, somatic cell nuclear
transfer.
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CHAPTER 1
INTRODUCTION

The majority of cells in an organism differ both morphologically and functionally
from one another (i.e. epithelial, muscle, connective, neural cells). However, they all
originate from a single cell, the zygote, which through several cell divisions gives rise to
all cell types. Once differentiated, each cell passes its specialized character on to the
daughter cells ensuring the preservation of the appropriate tissue type. The genes that are
transcriptionally active on the cells of a particular type are roughly the same, and differ
from those expressed in a different type. The pattern of gene expression characteristic for
a differentiated cell is “remembered” through subsequent cell divisions. The differences
in gene expression among cell types are not genetic since, with very few exceptions, most
cells in an organism contain exactly the same DNA sequence. These differences are
epigenetic. The term “epigenetics” was introduced during the 1940’s by Conrad H.
Waddington to describe "the events which lead to the unfolding of the genetic program"
(Holliday, 2006). Epigenetics was applied forty years later to describe “the interactions
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between genes and the cellular environment that produce a change in the cell phenotype”
(Holliday, 1987).
As cells differentiate and specialize to become a particular cell type a “cellular
memory” is established ensuring that only a specific set of genes will be transcribed and
others will be silent (Eilertsen et al., 2007). The molecular mechanisms necessary to
establish the cell memory include packaging unexpressed genes into more compacted
forms of chromatin that are “marked” to repress the expression of the genes. DNA
methylation, chromatin packaging, and remodeling of chromatin-associated proteins,
such as linker histones, polycomb group, and nuclear scaffold proteins (Latham, 1999;
Rideout et al., 2001) are some of the epigenetic mechanisms stably passed from cell to
cell during cell division, ensuring the maintenance of distinctive cell types.
Although the epigenetic marks in somatic cells are stable, they can be removed, to
a certain degree, and most cell types can be reprogrammed into becoming a different cell
type. Furthermore, a somatic cell can be reprogrammed to develop into an embryo and
become a new organism. One of the ways in which reprogramming of a differentiated
cell can be achieved is Somatic Cell Nuclear Transfer (SCNT), commonly referred to as
cloning. The somatic nucleus or even the whole somatic cell is transferred into an
enucleated oocyte, from which its own genomic DNA has been removed (Campbell et al.,
2001). After nuclear transfer, the oocyte is activated to start embryogenesis and finally
generate a new organism (Campbell et al., 2007). Despite the technological advances in
SCNT during the last decade, and its scientific and medical importance, the molecular
processes involved in nuclear reprogramming remain largely unknown and the overall
2

efficiency of SCNT in mammals remains low. The efficiency of cloning, defined as the
proportion of transferred embryos that result in viable offspring stands at 2-3% for all
species. Cattle seem to be an exception with efficiency averaging 5–20% for this species.
(Gurdon and Byrne, 2003; Sakai et al., 2005; Cibelli, 2007b; Oback and Wells, 2007b;
Niemann et al., 2008). Failure to reprogram the donor genome is thought to be one of the
main reasons for the low efficiency of cloning (Latham, 2005; Niemann et al., 2008).
One of the applications of SCNT is the production of human proteins in the milk
of transgenic animals. Genetic modifications are performed on cultured cells, which are
later used as nuclear donors to obtain transgenic animals by SCNT. Some of the
transgenic phenotypes require multiple genetic modifications, but it is unlikely that
somatic cells would divide for a sufficient length of time to allow for more than one
genetic modification to be completed (Kasinathan et al., 2001a). It has been proposed that
consecutive rounds of cloning, also referred to as “serial cloning”, allow for rejuvenation
and selection of transformed cultured cells (Hill et al., 2000; Hill et al., 2001; Liu et al.,
2001; Kuroiwa et al., 2004) and that it may improve the efficiency of SCNT by
increasing the reprogrammable potential of the somatic cells (Cho et al., 2007; Fujimura
et al., 2008). Conversely, other reports suggest that epigenetic errors could accumulate in
the embryos as a result of serial cloning and prolonged in vitro culture decreasing cloning
efficiency. After serial cloning up to the sixth generation was performed in mice, cloning
efficiency significantly decreased, although no signs of telomere shortening or premature
ageing were observed (Wakayama et al., 2000). A greatly reduced in vitro and in vivo
developmental capacity was reported for bovine embryos derived after several rounds of
serial cloning (Peura et al., 2001; Kubota et al., 2004). It has been suggested that
3

extended culture associated with transfection and selection procedures may induce
changes of somatic cells, which decrease the efficiency of nuclear transfer and that these
changes cannot be reversed by recloning (Zakhartchenko et al., 2001).
Our central hypothesis is that improper molecular reprogramming (inefficient
chromatin remodeling and DNA demethylation) in Somatic Cell Chromatin Transfer
(SCCT) derived embryos is causative of alterations in gene expression, which are
incremented by sequential rounds of cloning and negatively affect cloning efficiency. To
test this hypothesis, our objectives were (1) to determine the extent of transcriptional
reprogramming in blastocyst produced by SCCT, by comparing them to the transcriptome
profiles of the somatic cells used as nuclear donors; (2) to identify cumulative errors in
the transcriptome profile of bovine blastocysts produced by serial cloning (from the first
and fourth generations), using blastocysts produced by in vitro fertilization (IVF) as
controls; (3) to define the identities, roles, and expression patterns of important groups of
genes in molecular reprogramming; (4) to identify the mechanism(s) of molecular
reprogramming; (5) to determine the expression pattern of a panel of selected genes, in
fibroblasts obtained from fetuses from zero to five rounds of serial cloning; (6) to
describe the structural and functional conservation of DNA methyltransferases, and their
expression patterns during early embryonic development; (7) to contribute in the
annotation of genes involved in DNA methylation and chromatin remodeling.
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CHAPTER 2
REVIEW OF PERTINENT LITERATURE

2.1 Somatic Cell Nuclear Transfer
The first successful nuclear transfer experiments were conducted by Briggs and
King in 1952 using the frog Rana pipiens. When nuclei from blastula stage cells were
transplanted into enucleated eggs, normal looking tadpoles were obtained. However, the
cloned tadpoles never reached sexual maturity (Briggs and King, 1952). When nuclei
from older, more differentiated endoderm cells were transplanted into eggs, the embryos
failed to develop (Briggs and King, 1957). These findings suggested that as cell
differentiation progresses, irreversible changes render the nucleus incapable of being
reprogrammed. In 1962, biologist John Gurdon succeeded where Briggs and King had
failed, performing nuclear transfer using fully differentiated cells from the intestine of a
Xenopus laevis tadpole. Fertile adult frogs were obtained in this study (Gurdon et al.,
1958) proving that the nucleus was able to be reprogrammed despite the differentiated
status of the cell. Gurdon stated that “cell differentiation takes place without any stable
changes to the genome”. In the following years, Gurdon and his colleagues performed
5

several nuclear transfer experiments using somatic cells from a variety of tissues (Gurdon
and Uehlinger, 1966; Gurdon et al., 1975; Gurdon, 2006).
In the 1980s several studies proved that, like amphibian cells, mammalian cells
could also be reprogrammed. McGrath and Solter in 1983 successfully transplanted
nuclei from embryonic cells of mice into enucleated zygotes (Illmensee and Hoppe,
1981; McGrath and Solter, 1983). Willadsen, a domestic animal embryologist at
Cambridge University, repeated these experiments obtaining fully viable embryos using
sheep blastomeres (from 8- and 16-cell embryos) as donor cells and enucleated oocytes
as recipients (Willadsen, 1986). During the late 1980s and early 1990s, research
conducted in Neal First’s laboratory at the University of Wisconsin, resulted in cloned
cattle and pigs obtained by using blastomeres (from 8- to 32-cell stage embryos) as
nuclear donor cells (Prather et al., 1987; Robl et al., 1987). In 1994, the same group
achieved, for the first time, the birth of normal calves derived from primary cultures of
inner cell mass (ICM) cells that had been cultured for up to 27 days (Sims and First,
1994). In 1995, at the Roslin Institute in Edinburgh, two cloned lambs were born after
nuclear transfer from an established embryonic cell line (from a day-9 embryo), which
had been cultured for 6 to 13 passages (Campbell et al., 1996). One year later, the same
group produced eight more cloned lambs. One of the lambs was “Dolly” the first
mammal in history obtained by transfer of an adult somatic cell (mammary gland cell)
nucleus (Wilmut et al., 1997). Since then, a wide range of somatic cells from several
mammalian species has been used to perform SCNT (Cibelli et al., 1998; Wakayama et
al., 1998; Baguisi et al., 1999; Polejaeva et al., 2000; Chesne et al., 2002; Shin et al.,
2002; Galli et al., 2003; Woods et al., 2003; Zhou et al., 2003; Lee et al., 2005; Li et al.,
6

2006; Kim et al., 2007). The first reports of live offspring from thirteen mammalian
species obtained by SCNT are summarized in Table 1.1.

Table 2.1

First reported offspring in different mammalian species obtained by
somatic cell nuclear transfer from adult cells.
Year

Species

Donor cell type

Citation

1997

Sheep

Mammary epithelium

Wilmut et al.

1998

Cow

Fetal fibroblasts

Cibelli et al.

1998

Mouse

Cumulus cells

Wakayama et al.

1999

Goat

Fetal fibroblasts

Baguisi et al.

2000

Pig

Granulosa cells

Polejaeva et al.

2002

Rabbit

Cumulus cells

Chesne et al.

2002

Cat

Cumulus cells

Shin et al.

2003

Horse

Skin fibroblasts

Galli et al.

2003

Rat

Fetal fibroblasts

Zhou et al.

2003

Mule

Fetal fibroblasts

Woods et al.

2005

Dog

Skin fibroblasts

Lee et al.

2006

Ferret

Cumulus cells

Li et al.

2007

Wolf

Skin fibroblasts

Kim et al.

The overall efficiency of SCNT, defined as the proportion of transferred embryos
that result in viable offspring, stands at 2-3% for all species (Gurdon and Byrne, 2003;
Sakai et al., 2005; Cibelli, 2007b; Oback and Wells, 2007b). In cattle, SCNT has reached
a greater efficiency, averaging 5-10% and with some reports of efficiency as high as 20%
(Kato et al., 1998). Among the factors contributing to the greater success in cloning cattle
may be the late embryonic genome activation specific for this species (Memili et al.,
7

1998; Memili and First, 2000; Misirlioglu et al., 2006) coupled with the optimization of
reproductive technologies, such as in vitro embryo production and embryo transfer,
brought about by the cattle industry (Dinnyes et al., 2002). Additionally, the efficiency of
nuclear transfer technology in cattle may be enhanced by the fact that approximately half
of all SCNT’s worldwide are performed in this species (Oback and Wells, 2007a).
Failure to reprogram the donor genome is thought to be one of the main reasons
for the low efficiency of cloning (Bourc'his et al., 2001; Dean et al., 2001; Rideout et al.,
2001; Mann and Bartolomei, 2002). Various strategies have been employed to improve
the success rate of SCNT, most of them focus on the donor cells including: a) use of
different cell types as nuclear donors (Hill et al., 2000; Kato et al., 2000; Kato et al.,
2004; Inoue et al., 2005); b) use of donor cells cultured for different number of passages
(Zakhartchenko et al., 1999; Kubota et al., 2000; Jang et al., 2004); c) the importance of
the cell cycle stage of the donor nucleus (Smith et al., 1996; Kasinathan et al., 2001a;
Kasinathan et al., 2001b; Campbell and Alberio, 2003; Wells et al., 2003); and d) use of
chemical agents and cellular extracts to modify the donor cell epigenetic marks (Jones et
al., 2001; Enright et al., 2003; Enright et al., 2005). The influence of different oocyte
enucleation, fusion, and activation methods on cloning efficiency has also been analyzed
(Wang et al., 2001; Liu et al., 2002; Akagi et al., 2003).
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2.2 Somatic Cell Chromatin Transfer
Somatic Cell Chromatin Transfer (SCCT) was first described in 2004 as a strategy
to improve nuclear reprogramming (Sullivan et al., 2004). Somatic cells were exposed to
an extract from mitotic cells prior to transfer into enucleated oocytes. Mitotic cell extracts
induced condensation of somatic chromosomes and promoted removal of nuclear factors
from the somatic nucleus. The overall efficiency of producing cloned calves by CT was
similar to NT. Nevertheless, CT exhibited a trend toward enhanced survival of cloned
calves after one month postpartum. Mitotic cell extracts elicit ATP-dependent
condensation of chromosomes, and disassembly of the type A and B lamins from
chromatin. Additionally, transcription factors such as the TATA-box binding protein
(TBP) are removed from chromatin in the presence of mitotic cell extracts (Sullivan et
al., 2004).
The nuclear lamina is a meshwork of protein filaments, which consists of major
protein components including three major lamins, A, C, and B1 and a number of minor
lamins (Goldman et al., 2002). Lamins are classified into A-type (A, C, AD10, and C2)
and B-type lamins (B1, B2, and B3) and are involved in nuclear stability, chromatin
structure and gene expression (Hall et al., 2005a). While the B-type lamin B2 is
ubiquitously expressed in all cells, the lamins B1 and A/C are differentially regulated
throughout development and in adult tissues (Broers et al., 1997; Gruenbaum et al.,
2000). Expression of lamin B1 has been detected in the immature, germinal vesicle (GV)
oocyte and throughout early embryogenesis in murine, bovine and porcine embryos
(Constantinescu et al., 2006). Contrastingly, A-type lamins are primarily found in
9

differentiated cells. During mouse embryonic development, expression of A-type lamins
is first detected on day 9 in extraembryonic tissues and on day 12 in the embryo itself
(Prather et al., 1989).
In vitro and in vivo manipulations of nuclear lamina composition have shown that
failure to assemble a correct set of lamins invariably leads to apoptosis (Steen and Collas,
2001). Inappropriate assembly of type A lamins has been detected in NT embryos, along
with enhanced pronuclear TBP content, and increased resistance of DNA to DNAse I
(Sullivan et al., 2004). Remodeling a somatic nucleus in vitro through condensation of
chromosomes during interphase seems to alter the ‘‘memory’’ of chromatin organization
in the somatic nucleus (Gerlich et al., 2003). The removal of these somatic factors from
the donor nucleus could facilitate the incorporation of maternal chromatin remodeling
factors. Although a recent study did not detect any significant differences in the global
gene expression profiles of SCCT and SCNT embryos (Zhou et al., 2007), SCCT may
represent a tool for studying nuclear reprogramming.

2.3 Serial Cloning
One of the applications of SCNT is the production of biopharmaceuticals such as
human proteins in the milk of transgenic animals. Genetic modifications are performed
on cultured cells, which are later used as nuclear donors to obtain transgenic animals by
SCNT. Some of the transgenic phenotypes require multiple genetic modifications, but it
is unlikely that somatic cells would divide for a sufficient length of time to allow for
more than one genetic modification to be completed (Kasinathan et al., 2001a). It has
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been proposed that consecutive rounds of cloning, also referred to as “serial cloning”,
allow for rejuvenation and selection of transformed cultured cells (Hill et al., 2000; Hill
et al., 2001; Liu et al., 2001; Kuroiwa et al., 2004) and that it may improve the efficiency
of SCNT by increasing the reprogramming potential of the somatic cells (Cho et al.,
2007; Fujimura et al., 2008). Conversely, other reports suggest that developmental
capacity is reduced for bovine embryos derived after several rounds of serial cloning
(Peura et al., 2001; Kubota et al., 2004). Serially cloned mice, up to the sixth generation
showed no signs of telomere shortening or premature ageing. However, cloning
efficiency significantly decreased with increasing rounds of cloning (Wakayama et al.,
2000). It has been suggested that extended in vitro culture associated with transfection
and selection procedures may induce changes of somatic cells, which decrease the
efficiency of nuclear transfer and that these changes cannot be reversed by recloning
(Zakhartchenko et al., 2001).

Although the cellular and molecular events that take place during nuclear
reprogramming are simultaneous and integrated they will be studied separately in the
present review, for the sake of simplicity. First, the review focuses on the reprogramming
machinery of the oocyte and the changes in chromatin structure that occur after
fertilization and nuclear transfer. The second part of the review deals with epigenetic
modifications including DNA methylation, gene imprinting, and X-chromosome
inactivation, and their alterations after nuclear transfer. The expression patterns of genes
that are crucial for embryonic development are discussed, focusing on the differences
among embryos produces by fertilization and those produced by nuclear transfer. Finally,
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the review describes the current strategies used for improving nuclear reprogramming
and the future application of these to enhance cloning efficiency.

2.4 Reprogramming Factors in the Oocyte
Erasing the epigenetic marks of a somatic nucleus is a complex process that
requires global changes in DNA methylation, chromatin structure, gene imprinting, X
chromosome inactivation, and restoration of telomere length (Han et al., 2003b). A
somatic cell cannot reprogram its own epigenome. However, the egg is a cell with
“extensive experience” in reprogramming the genome of other cells. Once a sperm enters
the oocyte during fertilization, its nucleus is surrounded by the oocyte machinery
designed to reprogram the paternal genome. Although the entire process is not
completely understood, it is known that sperm reprogramming involves remodeling of
chromatin through removal of protamines and replacement by maternal histones. This
event is closely followed by genome-wide demethylation to create the basis for proper
gene regulation during embryogenesis (Reik et al., 2001; Santos et al., 2002; Santos et al.,
2005). The oocyte genome is also subjected to demethylation and chromatin remodeling,
but it happens after several cleavage divisions by a replication-dependent mechanism,
based on the loss of maintenance methylase activity (Mayer et al., 2000). The analysis of
methylation reprogramming in uniparental (parthenogenetic, gynogenetic, and
androgenetic) embryos indicates that the reprogramming machinery in the egg cytoplasm
treats the paternal and the maternal genomes in markedly different ways (Barton et al.,
2001).
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The same machinery that reprograms the sperm and oocyte genomes is the one
responsible of erasing the “cellular memory” and reprogramming the donor nucleus after
SCNT. However, since spermatozoa and somatic cells have such different chromatin
structure and DNA methylation patterns, it is understandable that the oocyte may not
reprogram a somatic nucleus with the same efficiency it reprograms the sperm DNA.
Somatic nuclear reprogramming is delayed and incomplete when compared to sperm
nuclear reprogramming (Latham, 2005). It can be argued that that the reprogramming of
a somatic genome resembles the reprogramming of the maternal pronucleus undergoing a
gradual replication dependent demethylation. The nuclear reprogramming event caused
by SCNT could be considered a transdifferentiation process that implies the molecular
dominance of one distinct cell type (the oocyte cytoplasm) over another (the somatic
nucleus), resulting in transformation of the somatic nucleus into a totipotent nucleus
(Western and Surani, 2002). The epigenetic marks in cloned embryos, fetuses, and adults
from several species do not always correlate to those of their counterparts produced by
fertilization. The low efficiency of cloning and the high levels of early and later
embryonic lethality suggest that epigenetic reprogramming after SCNT is a complex
process and its failure could result in fundamental and systematic errors (Dean et al.,
2003; Jouneau and Renard, 2003).
Several different outcomes of SCNT have been observed ranging from embryos
that fail to develop, up to the few cloned animals that have reached adulthood with no
evident pathologies. Between these two distinct outcomes, there is a range of cloned
animals that reach different stages. Some cloned embryos die during the earlier or later
stages of pregnancy, while some make it all the way to term, but die during the perinatal
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period. These outcomes could be the manifestation of different degrees of nuclear
reprogramming. The first one could be a complete failure of the oocyte machinery to
break down the nuclear membrane and reprogram the somatic chromatin, which would
result in death of the NT embryo. A partial reprogramming of vital genes for initial
development, would allow initial survival and development of the clone through the first
developmental stages resulting later in an abnormal phenotype or lethality. Finally, a
complete reprogramming would produce a normal animal (Rideout et al., 2001). The
results from hundreds of SCNT experiments indicate that complete reprogramming
happens only in a small proportion of the nuclear transfers (Panarace et al., 2007).
Oocytes are not the only cells capable of reprogramming the genome of other
cells. Pluripotential embryonic stem (ES) cells, which are derived from the inner cell
masses of blastocysts, have an intrinsic capacity for reprogramming nuclei of somatic
cells. In vitro hybridization of somatic cells with ES cells leads to reprogramming of the
somatic cells. The pluripotency of the ES-somatic hybrids has been proven as they
contribute to all three primary germ layers of chimeric embryos (Beddington and
Robertson, 1989; Nagy et al., 1993). The somatic pattern of DNA methylation is
maintained in the hybrids, indicating that ES cells only have the capacity to reset certain
aspects of the somatic cell epigenome (Tada et al., 2001; Tada et al., 2003). The use of
ES cells will contribute to elucidating the mechanisms of epigenetic reprogramming
involved in DNA and chromatin modifications (Tada and Tada, 2006). Individual oocyte
and ES cell reprogramming factors are being used in cell-free reprogramming extracts.
These and other agents that could improve the efficiency of nuclear reprogramming will
be discussed later in the review.
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2.5 Epigenetic Regulation of Development

2.5.1 Chromatin Remodeling in Early Embryonic Development
The basic unit of chromatin is the nucleosome, which is comprised of 147 base
pairs of DNA wrapped around an octamer of histones, formed by pairs of each of the four
core histones (H2A, H2B, H3, and H4). Each nucleosome is linked to the next by small
segments of linker DNA. Chromatin is further condensed by winding in a
polynucleosome fiber, which may be stabilized through the binding of histone H1 to each
nucleosome and to the linker DNA (Wade and Kikyo, 2002). Enzymatic modifications of
histones include phosphorylation, methylation, acetylation and ubiquitination, or the
removal of these modifications (Nakao, 2001). These modifications are recognized by
other structural proteins and enzymes, which together may stabilize the pattern of gene
expression.
Little is known about the initial molecular events that ensure nuclear
reprogramming in the mammalian oocyte. A significant proportion of the knowledge we
have about nuclear reprogramming comes from the transfer of mammalian somatic cells
into frog oocytes (Byrne et al., 2003) which, due to their size and availability, represent
an appropriate system for the study of nuclear reprogramming. A number of structural
proteins and enzymes that modify chromatin structure have been identified and are
principal candidates for regulating early reprogramming events. Within an hour of the
nuclear transfer, the mammalian somatic nuclear membrane breaks down, mimicking the
breakdown of the sperm nuclear envelope after fertilization (Gao et al., 2004). The
second event after SCNT appears to be condensation of the somatic cell chromosomes
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upon exposure to the M-phase ooplasm, which directs the formation of a new spindle
(Wakayama et al., 1998). In Xenopus laevis, somatic nuclei lose more than 85% of their
own proteins when transferred into an enucleated oocyte, while simultaneously
incorporating a substantial amount of protein from the cytoplasm (Gurdon et al., 1979).
Oocyte activation leads to the formation of “pseudopronuclei” that resemble the
pronuclei formed after fertilization but contain a random assortment of maternal and
paternal chromosomes. Often two “pseudopronuclei” are formed but the formation of
only one or more than two has been observed in mice (Latham et al., 2007). The
successful union of the pseudopronuclei occurs at the first mitotic division, as it does in
normal fertilized embryos (Latham, 2005). After SCNT, a global transcriptional silencing
has been observed in mouse, cattle and rabbit clones (Latham et al., 1994; Kanka et al.,
1996; Winger et al., 2000), followed by reappearance of the first signs of transcriptional
activity by the two-cell stage, resembling embryonic genome activation after fertilization
(Latham et al., 1994; Rideout et al., 2001).
The linker histone H1 may be involved in the regulation of gene expression
during embryogenesis (Clarke et al., 1998). Somatic H1 is lost from most mouse nuclei
soon after transfer. The rate of loss depends on the cell cycle stage of donor and recipient
cells (Bordignon et al., 2001). Bovine linker histone H1 becomes undetectable in somatic
nuclei within 60 minutes after injection into bovine oocytes, and is completely replaced
with the highly mobile oocyte-specific linker histone variant H1FOO (Gao et al., 2004;
Teranishi et al., 2004), suggesting an important role for linker exchange in nuclear
chromatin remodeling. Histone 1 remains absent or in very low concentration in early
cloned embryos, but becomes detectable at the 8- to 16-cell stage, when major
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transcriptional activation of the embryonic genome occurs. At these stages, the oocyte
molecules are replaced by the embryo derived H1 in a similar fashion to what happens in
normally fertilized embryos (Bordignon et al., 1999). It seems that nucleoplasmin, along
with other proteins in the oocyte, are involved in the H1 removal (Wade and Kikyo,
2002). In contrast, core histones of somatic nuclei, especially H3 and H4, are not
removed, but are stably associated with the somatic DNA (Weisbrod et al., 1982; Misteli
et al., 2000).
Histone tails are subjected to a wide range of postranslational modifications,
including acetylation, phosphorylation, and methylation, which are also implicated in
transcriptional silencing. Acetylated lysines on core histones (H3K9, H3K14, H4K16) of
somatic cells have been observed to be quickly deacetylated following SCNT. Their
reacetylation was observed following activation treatment in cloned mouse embryos.
However, the acetylation of other lysine residues on core histones (H4K8, H4K12) persist
in the genome of cloned embryos with only mild deacetylation occurring in the process of
SCNT and activation treatment (Wang et al., 2007). In somatic cells, transcriptionally
active 5S rRNA genes are packaged with hyperacetylated histone H4. In contrast, the
silent oocyte 5S rRNA genes are associated with hypoacetylated histone H4, suggesting
that hyperacetylation of histone H4 is necessary for transcriptional activity (Howe et al.,
1998). It could be argued that after SCNT, the cloned embryos establish a histone
acetylation pattern that partially resembles that of embryos produced by fertilization. The
same has been reported for histone phosphorylation. Histone H3–S10 and H3–S28 were
phosphorylated and dephosphorylated in the somatic chromatin in a manner paralleling
the changes in oocyte chromosomes (Bui et al., 2006).
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Histone acetylation and DNA methylation are tightly coupled through protein
complexes containing DNA methyltransferase, DNMT1, and histone deacetylases,
HDAC (Robertson et al., 2000) (Rountree et al., 2000). The role of the DNA cytosinelike 5-methyltransferase (DNMT3L) protein in the activation of Histone deacetylase 1
(HDAC1) (Deplus et al., 2002; Turek-Plewa and Jagodzinski, 2005) and targeting of
unmethylated lysine on histone 3 tails (H3K4) (Ooi et al., 2007), provides another link
between DNA methylation and histone acetylation that will be discussed later.
Along with histones, a number of non-histone nuclear proteins are also actively
released from or incorporated into somatic chromatin after nuclear transfer (Kikyo et al.,
2000). One such example is the basal transcription factor TATA binding protein (TBP)
that is released from somatic chromatin by a chromatin remodeling protein complex
(ISWI, a member of the SWI2/SNF2 super family) in the oocyte cytoplasm (Kikyo et al.,
2000; Wade and Kikyo, 2002). The helicase activity of these multisubunit ATPdependent enzymes unwinds DNA and redistributes nucleosomes in a tissue-specific
manner (Nakao, 2001). The loss of a principal component of the basal transcriptional
complex from somatic nuclei incubated in frog oocyte extract, provided the first
indication that members of the SWI/SNF family of enzymes may have roles in the
development of cloned embryos (Kikyo et al., 2000; Wilmut et al., 2002). Members of
the high mobility group proteins (HMG), particularly those corresponding to the
Nucleosomal subfamily (HMGN), are also actively removed from chromatin and later
incorporated into it (Phair and Misteli, 2000; Shirakawa et al., 2000). These results
suggest that the exchange of chromatin proteins between somatic nuclei and oocyte
cytoplasm are similar to the physiological protein exchange that occurs after fertilization.
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A schematic representation of the factors involved in nuclear reprogramming and
chromatin remodeling molecules after nuclear is presented in Figure 2.1.
The report of shortened telomere length in Dolly the sheep lead the authors to
conclude that “nuclear transfer does not restore telomere lengths” (Shiels et al., 1999).
However, restoration or elongation of telomere length after SCNT has been documented
in several species (Wakayama et al., 2000; Betts et al., 2001), even when senescent
fibroblasts with drastically shortened telomeres were used as donor cells (Lanza et al.,
2000). The length of telomeres, appears to be efficiently reprogrammed following NT
suggesting that telomere shortening is not significantly impeding development of clones
(Hochedlinger and Jaenisch, 2002). Serial cloning up to the sixth generation was
performed in mice. Although no signs of telomere shortening or premature ageing were
observed, cloning efficiency significantly decreased with increased rounds of cloning
(Wakayama et al., 2000).
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Figure 2.1

Schematic representation of oocyte factors that participate in
chromatin remodeling and reprogramming of the somatic nucleus.
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2.5.2 DNA Methylation in Early Embryonic Development
In mammalian cells, stable silencing of genes is frequently correlated with DNA
methylation of promoter regions, along with specific modifications in the N-terminal tails
of histones. DNA methylation is restricted to cytosine (C) residues in CG dinucleotides.
DNA methylation is the most studied epigenetic mechanism used by the cell for the
establishment and maintenance of a controlled pattern of gene expression (Quina et al.,
2006). DNA methylation provides a genome-wide means of regulation, usually
associated with the inheritance of lineage-specific gene silencing between cell
generations (Robertson and Wolffe, 2000). The patterns of DNA methylation are distinct
for each cell type and confer cell type identity (Szyf, 2005a). With few exceptions,
unmethylated DNA is associated with an active chromatin configuration while
methylated DNA is associated with inactive chromatin (Szyf, 2005b).
DNA methylation is accomplished by four DNA methyltransferases. The first
DNA methyltransferase to be discovered, DNMT1, maintains the methylation pattern
following DNA replication by using the parental DNA strand as a template to methylate
the daughter DNA strand. This means that CG sequences paired with methylated CG
dinucleotides are methylated by DNMT1 (Bestor et al., 1992; Pradhan et al., 1999).
DNMT2, the smallest mammalian DNA methyltransferase, contains only the five
conserved motifs of the C-terminal domain. Its function in DNA methylation has been
enigmatic (Yoder and Bestor, 1998; Dong et al., 2001). While some studies report that
DNMT2 has a role in DNA methylation (Kunert et al., 2003; Liu et al., 2003b; Tang et
al., 2003), others have detected little DNA methylation activity for this enzyme
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(Hermann et al., 2003; Rai et al., 2007). Recent research has demonstrated that DNMT2
methylates tRNAAsp in the cytoplasm (Goll et al., 2006; Jeltsch et al., 2006). Other two
members of this protein family, DNMT3a and DNMT3b have been identified as de novo
methyltransferases. These enzymes establish new DNA methylation patterns by adding
methyl groups to unmethylated DNA, particularly during early embryonic development
and gametogenesis (Okano et al., 1998; Okano et al., 1999).
Prior to fertilization, the genomes of both spermatozoa and oocytes are
transcriptionally inactive and highly methylated (Reik et al., 2001). Within hours of
fertilization, a dramatic genome-wide loss of DNA methylation has been reported in the
male pronucleus (Mayer et al., 2000; Oswald et al., 2000). Several mechanisms have
been suggested for the active demethylation of the paternal genome. Firstly, the removal
of the methyl group from the cytosine, secondly, the removal of the methyl-cytosine base
by glycosylation, and thirdly the removal of a number of nucleotides (excision repair)
(Dean et al., 2003). The nature of the mechanisms involved in the active demethylation of
the paternal genome remains known. After several cleavage divisions, the female
pronucleus is also demethylated. However this process seems to be passively caused by a
loss of methyl groups during each round of DNA replication due to the lack of DNMT1
(Mayer et al., 2000; Oswald et al., 2000). The only methylation marks preserved in the
embryonic genome are thought to be the ones on the imprinted genes (Oswald et al.,
2000; Reik et al., 2001; Young and Beaujean, 2004).
By the blastocyst stage, the embryo is hypomethylated (Monk et al., 1987). New
methylation patterns are established, around the blastocyst stage, by the de novo DNA
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methyltransferases, DNMT3a and DNMT3B, which add methyl groups to unmethylated
CG dinucleotides. Once the new patterns of methylation are established, they can be
propagated through rounds of DNA replication by DNMT1. Oocytes express an exclusive
shorter isoform of DNMT1 called DNMT1o, which lacks 114 amino acids from the Nterminal domain since its translation initiation lies on exon 4 instead of exon 1 (Bestor,
2000). DNMT1o is stored in the cytoplasm of oocytes and early embryos (Ratnam et al.,
2002) and only at the eight-cell stage, is transiently translocated to the nucleus (Kurihara
et al., 2008). After implantation, maternal DNMT1o is soon replaced by the somatic
DNMT1, expressed by the embryonic genome. The absence of DNMT1o from the
nucleus during early embryonic development is in accordance with the global
hypomethylation of the embryonic genome (Oliveri et al., 2007). Figure 2.2 is a
schematic representation of the demethylation of paternal and maternal genomes after
fertilization.
DNMT3L is a protein that has been associated with the DNA methyltransferase
family although it lacks the methyltransferase motifs and therefore cannot methylate
DNA. However, DNMT3L possesses a nuclear localization signal sequence (NLS) that
enables its translocation to the nucleus and DNA binding. Recent results have shown that
the C-terminal domain of DNMT3L interact with DNMT3A forming a dimer. The de
novo methylation activity of DNMT3A, depends upon its dimerization with DNMT3L
(Jia et al., 2007). Additionally, DNMT3L has a Plant Homeodomain (PHD) like motif
that activates Histone deacetylase 1 (HDAC1) (Deplus et al., 2002; Turek-Plewa and
Jagodzinski, 2005) and recognizes histone H3 tails that are unmethylated at lysine 4 (Ooi
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et al., 2007). Thus, DNMT3L has a dual role in de novo DNA methylation, activating
DNMT3A and interacting with unmethylated H3 (Jia et al., 2007).

Figure 2.2 Schematic representation of the changes in DNA methylation in bovine
mature gametes and early embryos.
Note: DNA methylation is shown as arbitrary units in the Y axis. The DNA methylation
level of the preimplantation embryo is the sum of the spermatozoon and oocyte
methylation. The sperm genome undergoes active demethylation, while the oocyte
genome undergoes passive demethylation throughout several cell divisions. After the 8cell stage a small wave of de novo methylation is observed. By the blastocyst stage, the
DNA methylation level in the trophectoderm cells is markedly lower compared to cells of
the inner cell mass ICM. At the peri-gastrulation stage DNA methylation is regained in
the entire embryo.
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The exact biological function of this dynamic reprogramming of DNA
methylation in early development is unknown. Several studies demonstrate that DNA
methylation is crucial for the establishment of gene expression during embryonic
development (Eden and Cedar, 1994; Jones et al., 1998). However, other studies suggest
that DNA methylation may only affect genes that are already silenced by other
mechanisms in the embryo, indicating that DNA methylation could be a consequence
rather than a cause of gene silencing during development (Nan et al., 1998; Walsh and
Bestor, 1999; Bestor, 2000). Mutations in either the maintenance or the de novo
methyltransferases result in early embryonic death in mice (Li et al., 1992; Young and
Beaujean, 2004), indicating that the establishment and maintenance of appropriate
methylation patterns are crucial for normal development. For many years, it was believed
that the established methylation pattern was reliably and irreversibly maintained for the
life of the organism (Szyf, 2005b). However, recent data suggests that DNA methylation
is reversible and can change in response to intrinsic and environmental signals
(Ramchandani and McConachie, 2005). Modulation of DNA methylation during early
embryogenesis is a dynamic process that is developmentally regulated.
The study of DNA methylation after SCNT has shown that somatic cell chromatin
undergoes only limited demethylation after SCNT (Fulka and Fulka, 2007). Embryos
derived from nuclear transfer have an abnormal pattern of chromatin methylation, which
in some cases resembles that of donor cells and is retained through several cell divisions
in cloned embryos (Fairburn et al., 2002). The somatic-like methylation pattern
maintained in cloned embryos up to the 4-cell stage indicates that active demethylation is
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absent in nuclear transfer (Bourc'his et al., 2001). Other studies suggest that cloned
embryos undergo active demethylation, but lack passive demethylation (Dean et al.,
2001). It has also been reported that de novo DNA methylation starts precociously at the
4- to 8-cell stage in cloned embryos. By the 8 to 16-cell stage, cloned embryos showed a
heterogeneous methylation pattern with some nuclei appearing hypomethylated and
others hypermethylated. By the blastocyst stage, most nuclear transfer embryos seem to
establish a global DNA methylation level comparable to that of embryos produced by
fertilization. However, abnormally high methylation patterns are detected in some regions
of the genome (Kang et al., 2001; Han et al., 2003b; Beaujean et al., 2004). Figure 2.3 is
a schematic representation of the level of DNA demethylation after nuclear transfer as
compared to the one occurring in embryos produced by fertilization.
It is not clear to what extent the DNA methylation pattern observed during normal
development needs to be mimicked for cloning to succeed. Individual blastocysts display
significant alterations in the methylation pattern. However, such aberrant reprogramming
of DNA methylation does not seem to be lethal since several of the cloned embryos with
hypermethylated DNA undergo development beyond the blastocyst stage (Bourc'his et
al., 2001; Dean et al., 2001; Kang et al., 2001).
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Figure 2.3.

Schematic representation of the changes in DNA methylation in a
somatic nucleus after nuclear transfer.

Note: DNA methylation is shown as arbitrary units in the Y axis. The extent of DNA
demethylation of a somatic nucleus after SCNT is incomplete, compared to that of
embryos produced by fertilization (dashed line). Although by the 8- to 16-cell stage the
DNA methylation level of the cloned embryo has decreased considerably, the pattern of
methylation is heterogeneous in the blastomeres. The trophectoderm and ICM cells of
cloned blastocysts have similar methylation levels, unlike the differential methylation
observed in embryos produced by fertilization.
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Variation in imprinted gene expression has been observed in cloned mice.
Interestingly, many of these animals survive to adulthood despite widespread gene
misregulation, indicating that mammalian development may be rather tolerant to certain
levels of epigenetic aberrations of the genome (Humpherys et al., 2001). These data
imply that even apparently normal cloned animals may have subtle abnormalities in their
DNA methylation pattern. Conversely, other studies have inversely correlated aberrant
DNA methylation with the developmental potential of the cloned embryos (Santos et al.,
2003).
In female mammalian embryos at about the morula stage, nearly all genes in one
of the two X chromosomes are inactivated by a dosage compensation mechanism known
as X-chromosome inactivation (XCI) (Lyon, 1961). In fetal tissues this inactivation is
random; in some cells the inactivated X chromosome is paternal, while in others it is
maternal. However, in the trophectodermal cells, the paternal X-chromosome seems to be
the only inactivated one (Heard et al., 1997). Female embryos, obtained by nuclear
transfer, receive a somatic nucleus, which already has one inactivated X chromosome.
The recipient enucleated oocyte has to transiently activate the inactive X chromosome so
that the embryo can later accomplish the random X chromosome inactivation that occurs
in normal embryos. XCI has been monitored in cloned mouse embryos to study the
reprogramming of a somatic female nucleus. Normal XCI patterns have been reported in
cloned female tissues. Cloned female mice obtained from somatic cells with a
transcriptionally ‘inactive’ paternal X-chromosome showed a random X-chromosome
inactivation with an active paternal X-chromosome in some cells and an inactive one in
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other cells (Yanagimachi, 2002). However, the trophectoderm cells maintained the
inactivation of the X chromosome that was silent in the somatic cell, even when it was
the maternal one (Eggan et al., 2000). Similar results have been reported for live bovine
cloned calves. Additionally, aberrant XCI patterns have been detected in fetal and
placental tissues from deceased cloned bovine and mice fetuses (Ohgane et al., 2001; Xue
et al., 2002). Other studies have found significant failures in XCI in cloned mice and pigs
(Nolen et al., 2005; Jiang et al., 2008). To date, the role of abnormal XCI in the low
efficiency of cloning is not clear.

2.6 Gene Expression in SCNT derived Embryos
Differentiated cells have cell-specific gene expression. Genes transcriptionally
active in one type of cell, for example, may be silenced in another cell type. There are
genes, not all of them identified yet, whose activation means the difference between
development and failure in a cloned embryo. These genes ensure blastocyst formation,
implantation, and development to term, and their expression is the result of chromatin
remodeling and DNA methylation modifications. These modifications not only ensure
the activation of embryonic genes associated with a state of totipotency, but also the
down-regulation of somatic genes that are not necessary and could even be detrimental
for the embryo.
The global transcriptome profile of cloned embryos, relative to that of donor cells
and embryos produced by fertilization has been studied using microarray technology.
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Global alteration of gene expression has been reported in cloned embryos, which may
present upregulation of donor cell-specific genes (Ng and Gurdon, 2005). Abnormal
expression of genes playing important roles in early embryonic development,
implantation and fetal development is of particular interest. The expression of imprinted
genes was abnormal in cloned blastocyst at three levels: total transcript abundance, allele
specificity of expression, and allelic DNA methylation. This study reported methylation
and gene expression abnormalities for nearly all embryos and despite their morphological
quality with considerable heterogeneity among individual embryos (Mann et al., 2003).
These observations indicate that epigenetic marks associated with imprinted genes are not
faithfully retained in the majority of cloned embryos. The low proportion of embryos
exhibiting a comparatively normal pattern of imprinted gene expression at the blastocyst
stage is consistent with the proportion of live-born clones.
Conversely, other studies have reported a significant reprogramming of SCNT
embryos by the blastocyst stage and transcriptome profiles comparable to those of
embryos produced in vitro or in vivo, suggesting that defects in gene expression for
SCNT embryos may occur later during redifferentiation and/or organogenesis (Smith et
al., 2005; Somers et al., 2006; Yu et al., 2007). Identifying key genes responsible for the
general developmental failure in cloned embryos is not an easy task, since the alterations
may be caused by a variety of factors including donor cell type, cell cycle stage, nuclear
transfer protocol, source of the oocytes, embryo culture system, embryo transfer
procedure, management of recipient cows, and operators’ skills (Oback and Wells,
2007a). Consequently, there is a big variety of alterations that are not shared by all cloned
embryos. The common thread uniting many of the SCNT failures can be traced to
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epigenetic alterations, specifically failures in chromatin remodeling and DNA and histone
methylation (Vignon et al., 2002; Santos et al., 2003; Suteevun et al., 2006).
POU5F1, the gene, encoding the transcriptional regulator Oct4, which is induced
in somatic nuclei after nuclear transfer, has been one of the more studied markers of
pluripotency (Nichols et al., 1998; Byrne et al., 2003; Westphal, 2005). Demethylation of
the Oct4 promoter precedes reprogramming and is a prerequisite for its activation
(Simonsson and Gurdon, 2004). Some studies have reported POU5F1 misregulation in
SCNT embryos (Boiani et al., 2002; Beyhan et al., 2007a), while others report it at the
expected concentration (Daniels et al., 2000; Smith et al., 2007). POU5F1 mRNA levels
were comparable in bovine cloned embryos and embryos produced by in vitro
fertilization (Rodriguez-Osorio et al., 2008). No significant difference in POU5F1 mRNA
levels among cloned blastocysts and blastocysts produced by in vitro fertilization and
artificial insemination were detected by microarray analysis and real-time PCR (Zhou et
al., 2007). Another gene that has been extensively studied, due to its implication in the
large offspring syndrome (LOS), is the imprinted gene insulin-like growth factor 2
receptor (IGF2R) (Lazzari et al., 2002). This gene has shown altered expression values in
embryos produced in vitro and a marked misregulation in cloned embryos (Han et al.,
2003a; Yang et al., 2005).
Several genes have been reported to be abnormally expressed in bovine cloned
embryos including IL6, FGF4, FGFr2, FGF4, DNMT1, Mash2, HSP70, interferon tau,
histone deacetylases and DNMT3A (Daniels et al., 2000; Niemann et al., 2002; Beyhan
et al., 2007a). Oligonucleotide microarray analysis and Real Time PCR showed that
developmentally crucial genes such as Desmocollin 3 (DSC3), a transmembrane
31

glycoprotein involved in cell adhesion, and the high mobility group nucleosomal binding
domain 3 (HMGN3) were significantly downregulated in cloned bovine embryos
compared to in vitro produced embryos (Rodriguez-Osorio, article in press). The same
study found a significant downregulation in the signal transducer and activator of
transcription 3 (STAT3) in cloned bovine blastocysts, contrary to a report of upregulation
of this gene in cloned blastocyst (Zhou et al., 2007). The importance of these genes
during morula and blastocyst formation could make them good candidates in
understanding the poor developmental rates of cloned embryos. The lack of consistency
in the pattern of gene expression of some genes in different SCNT studies makes it
difficult to pinpoint the genes that are consistently misregulated after cloning. A recent
study reported abnormal expression of DNMTs, interferon tau (INFT) and major
histocompatibily 1 complex class 1(MHC1 1) transcripts in the majority of cloned bovine
embryos. This study reports a downregulation of DNMT3B in the majority of cloned
embryos on day 7 (Giraldo et al., 2008). Conversely, a significant upregulation in
DNMT3A and DNMT3B transcripts was indentified in cloned bovine embryos compared
to their in vitro produced counterparts (Rodriguez-Osorio, article in press). The role of
DNMT3A and DNMT3B in de novo methylation could link these enzymes with the,
already discussed, high methylation levels of cloned embryos. The lack of consistency in
the pattern of gene misregulation in cloned embryos in different studies has lead several
authors to suggest that nuclear reprogramming after somatic cell nuclear transfer is
stochastic in nature. According to this hypothesis, the number and the role of
misregulated genes determine the fate of each cloned embryo.
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2.7 Alternatives for Improving Nuclear Reprogramming
Improving the efficiency of SCNT is directly related to knowledge about
molecular reprogramming which is important for embryo formation and development
after nuclear transfer. Ooplasmic factors contributing to nuclear reprogramming are being
sought in hope of improving the outcome of SCNT and providing a better understanding
of mammalian embryogenesis (Sutovsky and Prather, 2004). A DNA demethylation
agent, 5-aza-29-deoxycytidine (5-aza-dC a derivative of the nucleoside cytidine), has
lowered DNA methylation and induced overexpression of imprinted genes in mouse
embryonic fibroblast cells by lowering DNA methylation levels (Eilertsen et al., 2007).
Treatment of donor cells with 5-azacytidine prior to nuclear transfer, may remove
epigenetic marks and improve the ability of somatic cells to be fully reprogrammed by
the recipient karyoplast (Enright et al., 2003). Unfortunately, 5-aza-dC reduced blastocyst
formation of cloned embryos (Tian et al., 2003).
A histone-deacetylase inhibitor, trichostatin A (TSA) enhances the pool of
acetylated histones and induces overexpression of imprinted genes in embryonic stem
cells (Yoshida et al., 1990; Wakayama, 2007). Demethylation of H3K9 tri- and
dimethylation might be crucial for further development of cloned embryos. Whether this
histone H3K9 demethylation is correlated with active DNA demethylation needs to be
investigated further (Wang et al., 2007). Treatment of cloned embryos with TSA could
affect the histone acetylation reprogramming.
No reports are yet available on how treating donor cells with these agents would
affect the development of cloned embryos to term. Reducing methylation by knocking33

down DNMT1 gene expression using small interfering RNA (siRNA) technology has
been applied to a bovine donor cell line with an approximately 30–60% decrease in
global DNA methylation. Demethylated cells were used subsequently for SCNT, which
doubled blastocyst rates suggesting that demethylation prior to NT may be beneficial for
NT-induced reprogramming (Eilertsen et al., 2007).
Decondensation of sperm chromatin in eggs is achieved by the replacement of
sperm-specific histone variants with egg-type histones by the egg protein nucleoplasmin.
Nucleoplasmin can also decondense chromatin in undifferentiated mouse cells without
overt histone exchanges but with specific epigenetic modifications that are relevant to
open chromatin structure. These modifications included nucleus-wide multiple histone
H3 phosphorylation, acetylation of Lysine 14 in histone H3, and release of
heterochromatin proteins HP1beta and TIF1beta from the nuclei. At the functional level,
nucleoplasmin pretreatment of mouse nuclei facilitated activation of four oocyte-specific
genes (Tamada et al., 2006). Nucleoplasmin injected into bovine oocytes after nuclear
transfer resulted in apparent differences in the rates of blastocyst development and
pregnancy initiation. Over 200 genes were upregulated in nucleoplasmin treated cloned
embryos, several of which were previously shown to be downregulated in cloned
embryos when compared to bovine IVF embryos (Betthauser et al., 2006). These data
suggest that addition of chromatin remodeling factors, such as nucleoplasmin, to the
oocyte may improve development of NT embryos by facilitating reprogramming of the
somatic nucleus.
Nuclear and cytoplasmic extracts that can transform one cell type into another
have been used as reprogramming factors. The procedure involves the permeabilization
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of a somatic cell (the "donor" cell) in a nuclear and cytoplasmic extract derived from
another somatic "target" cell (Hakelien et al., 2006a). The reprogramming ability of these
extracts has been evidenced by nuclear uptake and assembly of transcription factors,
induction of activity of a chromatin remodeling complex, changes in chromatin
composition, and expression of new genes (Hakelien et al., 2006b). These systems are
likely to constitute a powerful tool to examine the process of nuclear reprogramming. In
addition, cell-free extracts create possibilities for circumventing human SCNT (which
raises ethical, moral and legal issues) by producing replacement cells for therapeutic
applications (Collas, 2003). The recently reported use of four transcription factors (Oct4,
Sox2, Klf4, and c-Myc) (Yu et al., 2007) to produce pluripotent stem cells raises the
question of whether nuclear transfer is still necessary for the achievement of stem cells
for therapeutic purposes (Cibelli, 2007a). Nevertheless, the therapeutic use of such
induced pluripotent stem cells is not known yet.
A recent hypothesis suggests that failure in the oocyte reprogramming machinery
to target the paternal genome of the somatic nucleus originates an unbalanced nuclear
reprogramming between parental chromosomes. These authors suggest that exogenous
expression in donor somatic cells of a sperm chromatin remodeling proteins, particularly
the BRomo Domain Testis-specific protein (BRDT), could induce a male-like chromatin
organization of the somatic genome (Loi et al., 2008). The real advantages of such a
method remain to be observed since both the paternal and the maternal genomes, present
in the somatic nucleus, need to undergo reprogramming after nuclear transfer.
In addition to the multiple proteins that participate in chromatin remodeling and
DNA methylation, oocytes contain microRNAs (miRNAS) that regulate the expression of
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genes by inhibiting translation (Bartel, 2004). Several specific miRNas have been
isolated from Xenopus (Watanabe et al., 2005), Drosophyla (Nakahara et al., 2005), and
mouse oocytes (Tang et al., 2007). The function of miRNAs during early development is
not known yet, but their importance in early embryo development is supported by the fact
that mouse oocytes lacking miRNAs fail to cleave (Tang et al., 2007). Although the exact
role of miRNAs in nuclear reprogramming has not been explored, it has been proposed
that some developmental failures of cloned embryos might be a consequence of miRNA
alteration during nuclear transfer. Enucleation did not seem to remove substantial
amounts of oocyte miRNAs, while nuclear transfer significantly increased the oocyte
miRNA profile. Some miRNAs that play a role in somatic cells may be capable of
regulating the same or different mRNAs with distinct roles in embryogenesis following
their introduction to the oocyte by nuclear transfer (Amanai et al., 2006). Further studies
should focus on the role of somatic miRNA in early embryonic development.
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CHAPTER 3
TRANSCRIPTIONAL REPROGRAMMING OF GENE EXPRESSION
IN BOVINE SOMATIC CELL CHROMATIN
TRANSFER EMBRYOS

3.1 Abstract
Successful reprogramming of a somatic genome to produce a healthy clone by
SCNT is a rare event and the mechanisms involved in this process are poorly defined.
When serial or successive rounds of cloning are performed, blastocyst and full term rates
decline even further with the increasing rounds of cloning. Identifying the "cumulative
errors" could reveal the epigenetic reprogramming blocks in animal cloning. Bovine
clones from up to four generations of successive cloning were produced by chromatin
transfer. Using Affymetrix bovine microarrays we determined that the transcriptomes of
blastocysts derived from the first and the fourth rounds of cloning (CT1 and CT4,
respectively) have undergone an extensive reprogramming and were more similar to
blastocysts derived from in vitro fertilization (IVF) than to the donor cells used for the
first and the fourth rounds of chromatin transfer (DC1 and DC4 respectively). However a
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set of transcripts in the cloned embryos showed a misregulated pattern compared to IVF
embryos. Among the genes consistently upregulated in both CT groups compared to the
IVF embryos were genes involved in regulation of cytoskeleton and cell shape. Among
the genes consistently upregulated in IVF embryos compared to both CT groups were
genes involved in chromatin remodeling and stress coping. The present study provides a
unique data set for identifying epigenetic errors in somatic cell chromatin transfer and
understanding cell plasticity. Identifying the "cumulative errors" could reveal the
epigenetic reprogramming blocks in animal cloning shedding light on the reprogramming
process.

3.2 Introduction
The process of early embryonic development is determined by activation of the
embryonic genome, which for bovine embryos begins as a “minor genome activation” at
the 1-cell stage (Memili and First, 2000) ascending to a “major genome activation”
during the 8-cell to 16-cell stage (Whitworth et al., 2004). In the absence of proper
genome activation, the developing embryo will die because it can no longer support its
essential developmental functions (Latham and Schultz, 2001; Han et al., 2003b). In the
case of embryos produced by somatic cell nuclear transfer (SCNT) the somatic nucleus
has to be completely reprogrammed in order to restart and continue the developmental
process. It is believed that, guided by the ooplasm, the somatic nucleus aborts its own
program of somatic gene expression and re-establishes a particular program of embryonic
gene expression necessary for normal embryo development (Han et al., 2003b).
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Embryos produced by SCNT have lower developmental rates than their in vitro
and in vivo produced counterparts (Vajta and Gjerris, 2006). They also have a greater
incidence of apoptosis and consequently a lower number of cells (Prather, 2007). Cloned
embryos have overall greater rates of embryo and fetal mortality, stillbirths and perinatal
deaths, which bring down the overall efficiency of cloning and may be caused, at least
partially, by incomplete epigenetic reprogramming of the somatic nuclei (Ng and
Gurdon, 2005; Vajta and Gjerris, 2006). Somatic cell chromatin transfer (SCCT) attempts
to facilitate the reprogramming process by exposing the somatic cells, prior to the
transfer, to a mitotic cell extract, which is thought to induce chromosome condensation
and promote removal and solubilization of nuclear factors, enhancing nuclear remodeling
(Sullivan et al., 2004). Compared to nuclear transfer, SCCT shows greater survival of
cloned calves up to at least 1 month and could be a useful tool in understanding the
mechanisms of reprogramming. Remarkably, a recent study did not detect any significant
differences in the global gene expression profiles of SCCT and SCNT embryos (Zhou et
al., 2007).
Embryos derived from nuclear transfer have an abnormal pattern of chromatin
methylation, in some cases resembling that of somatic cells (Bourc'his et al., 2001; Dean
et al., 2001; Kang et al., 2001). This aberrant DNA methylation pattern has been
inversely correlated with the developmental potential of the cloned embryos (Santos et
al., 2003). Treatment of donor cells, before the nuclear transfer, with DNA demethylation
agents may remove epigenetic marks improving the ability of the somatic cells to be fully
reprogrammed by the recipient karyoplast (Enright et al., 2003). Global alteration of gene
expression has been another finding in embryos produced by cloning. The abnormal
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expression of genes playing important roles in early embryonic development,
implantation and fetal development is of particular interest. Conversely, other studies
have reported a significant reprogramming for SCNT embryos by the blastocyst stage and
similar transcriptome profiles to those of embryos produced in vitro or in vivo,
suggesting that defects in gene expression for SCNT embryos may occur later during
redifferentiation and organogenesis (Smith et al., 2005; Somers et al., 2006).
Among the abnormally expressed genes reported in bovine cloned embryos are
IL6, FGF4, and FGFr2 (Daniels et al., 2000); FGF4, DNMT1, Mash2, HSP70, and
interferon tau (Niemann et al., 2002); Acrogranin, Cdx2, and ERR2 (Hall et al., 2005b).
Cytokeratin 19, Cytokeratin 8, Vimentin, Hsp27, Nidogen2 and MHC-I (Pfister-Genskow
et al., 2005); HDAC-1, 2, and 3, DNMT3A, and OCT4 (Beyhan et al., 2007a). Lower
levels of transcripts involved in the retinoic acid signaling pathway (RARB, CRAB1,
HLA-A, THBS2, and SERPINB5) were reported for cloned bovine embryos (Beyhan et
al., 2007b). There have been conflicting results when it comes to the expression of
particular genes in SCNT and IVF embryos. Such is the case of the developmentally
important POU5F1 gene, which has been reported as misregulated in cloned embryos
compared to IVF derived blastocysts in some studies (Boiani et al., 2002; Beyhan et al.,
2007a), while being detected at similar concentration in others (Daniels et al., 2000;
Smith et al., 2007).
SCNT is often used for the production of human proteins in the milk of transgenic
animals. For the achievement of some specific transgenic phenotypes, multiple genetic
modifications should be completed through sequential modifications in primary cells
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prior to nuclear transfer. Since transfection and selection of transgenic cells requires
nearly the entire lifespan of a cell, only one genetic modification can be completed in
each cell lifespan (Wang and Zhou, 2003). Therefore, consecutive rounds of cloning (also
referred to “repeated cloning”, “serial cloning”, “recloning” or “nuclear recycling”) are
performed in order to facilitate the regeneration and rejuvenation of the cells (Kasinathan
et al., 2001a). However, it has been hypothesized that epigenetic errors could accumulate
in the embryos as a result of the serial cloning and decrease even more cloning efficiency
(Kasinathan et al., 2001a). Serial cloning in mice up to four and six generations showed a
general drop in cloning efficiency after the first generation. However no signs of
premature ageing, or telomeres shortening were observed in the animals (Wakayama et
al., 2000). A greatly reduced in vitro and in vivo developmental capacity was reported for
bovine embryos derived after several rounds of serial cloning (Peura et al., 2001; Kubota
et al., 2004). Normally appearing fetuses were recovered from a fifth generation of serial
cloning and four genetic modifications (Kuroiwa et al., 2004).
The objective of the present study was to identify the "cumulative errors" on
global gene expression, caused by serial rounds of SCCT, by comparing the
transcriptome profile of IVF derived blastocysts to that of SCCT derived blastocysts from
the first and fourth rounds of cloning (CT1 and CT4) using oligonucleotide microarray
analysis (Affymetrix Bovine GeneChips). Donor cells used for first and fourth rounds of
cloning (DC1 and DC4) were also the target of the study as we compared the global gene
expression of the SCCT embryos with their respective donor cells. Additionally, we
analyzed the expression patterns of a panel of selected genes, in fetal fibroblasts obtained
from fetuses from zero to fifth rounds of chromatin transfer. Our results show that a
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substantial reprogramming has taken place in the cloned embryos from both generations
of chromatin transfer. However, there was a set of differential expressed genes in both
groups of cloned embryos compared to their IVF counterparts. The number and functions
of these genes could suggest cumulative misregulations probably caused by the
successive rounds of cloning.

3.3 Methods

3.3.1 In Vitro Fertilization (IVF)
Bovine oocytes were aspirated from 2-8 mm follicles of abattoir-obtained ovaries
from Holstein cows and matured in Tissue Culture Medium (TCM-199, Gibco/
Invitrogen, Grand Island, NY) supplemented with 0.2 mM pyruvate, 0.5 µg/ml FSH
(Sioux Biochemicals, Sioux City, IA), 5 µg/ml LH (Sioux Biochemicals, Sioux City, IA),
10% FCS (Gibco/Invitrogen, Grand Island, NY), 100 U/ml penicillin and 100 µg/ml
streptomycin (Gibco/Invitrogen, Grand Island, NY) in 5% CO2 in air at 38.5ºC. For
fertilization, matured oocytes were transferred to fertilization medium and were fertilized
using thawed sperm from a Holstein bull separated by Percoll density gradient and
further incubated for 24 hours. Presumptive zygotes were transferred to Gardner’s culture
medium 1 (G1) for 3 days, followed by 3-4 days culture in Gardner’s culture medium 2
(G2). Blastocysts were evaluated and graded according the International Embryo
Transfer Society (IETS) guidelines (Stringfellow and Seidel, 1998). Grade 1 blastocysts
were selected, pooled in groups of 3 blastocysts per tube, frozen (with addition of lyses
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buffer from RNeasy MicroKit (Qiagen Valencia, CA) in liquid nitrogen and stored in 80ºC until RNA isolation.

3.3.2 Chromatin Transfer
In vitro-matured oocytes were enucleated at 20 hours post maturation (hpm).
Bovine fetal fibroblasts after one and four rounds of cloning were trypsinized and washed
in Ca/Mg Hank’s Balanced Salt Solution (HBSS) and permeabilized by incubation of
50,000 - 100,000 cells in 31.25 units Streptolysin O (SLO-Sigma, St. Louis, MO) in 100
μl for 30 minutes in a 37oC H2O bath. Permeabilized fibroblasts were washed, pelleted
and incubated in 40 μl of mitotic extract prepared from MDBK cells containing an ATPgenerating system (1 mM ATP, 10 mM creatine phosphate and 25 μg/ml creatine kinase)
for 30 min at 38oC. At the end of incubation, the reaction mix was diluted with 500 μl of
cell culture media (Alpha MEM with 10% FBS), pelleted and resuspended in TL Hepes.
These cells were fused to enucleated oocytes, activated 26 h after maturation with 5 μM
calcium ionophore for 4 min followed by 10 μg/ml of cycloheximide and 2.5μg/ml of
cytochalasin D for 5 h. After activation, embryos were washed, and cultured in SOF
medium for the first 4 days with 8 mg/ml BSA and the last three days with 10% fetal calf
serum at 38.5°C and 5% CO2 in air. Grade 1 blastocysts were pooled (3 per tube) and
frozen, with addition of lysis buffer. Embryos were stored in -80ºC until RNA isolation.
3.3.3 Fourth Generation of SCCT Embryos
For subsequent rounds of cloning, CT derived bovine blastocysts from the first
generation were transferred into hormonally synchronized cows. At seventy-days,
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pregnancies were interrupted, and fetuses recovered. Fetal fibroblast cultures were
established and used for the next chromatin transfer process. The same procedure was
done 3 times to provide a fourth generation of clones. Grade 1 blastocysts from the fourth
generation were pooled (3 per tube) and frozen, with addition of lysis buffer. Embryos
were stored in -80ºC until RNA isolation.

3.3.4 Establishment of Fetal Fibroblast Cell Lines
Seventy-day old male bovine fetuses were recovered and transported to the
laboratory in Dulbecco’s PBS (DPBS) with 16 ml/ml of antibiotic-antimycotic (Gibco,
Grand Island, NY), 4 ml/ml tylosin tartrate (Sigma, St. Louis, MO), and 8 ml/ml
fungizone (Gibco). Fetuses were rinsed in DPBS, the head and internal organs were
removed, and remaining tissues were finely chopped into pieces with a scalpel blade. The
fibroblasts were separated from the tissue pieces using 0.08% trypsin and 0.02% EDTA
in PBS (trypsin-EDTA). The cells were seeded onto 100-mm tissue culture plates
(Corning, VWR, Chicago, IL) in a minimal essential medium (a-MEM; Gibco)
supplemented with 10% fetal calf serum (FCS; Hyclone, Logan, UT), 0.15 g/ml
glutamine (Sigma), 0.003% b-mercaptoethanol (Gibco), and antibiotic-antimycotic
(Gibco). On the same day of cloning (day 3 of seeding), the cells were harvested using
DPBS with trypsin-EDTA solution and were counted. One million cells were frozen in
MEM with 10% FCS, dimethyl sulfoxide (Sigma), and lysis buffer.
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3.3.5 RNA Isolation
Total RNA was isolated from IVF blastocysts, SCCT blastocysts, and donor cells
using the RNeasy MicroKit (Qiagen Valencia, CA) according to the manufacturer’s
specifications. Briefly, embryos and cells frozen at -80˚C in lysis buffer were transferred
to silica-gel membrane spin columns and washed with RW1 wash buffer and 80%
ethanol. Final RNA elution was conducted using 14 μl of RNAse free water provided in
the kit. Concentration and purity of isolated RNA were determined using a NanoDrop®
ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Integrity and
quality were analyzed using a Bioanalyzer 2100 RNA 6000 Picochip kit (Agilent
Technologies, Palo Alto, CA).

3.3.6 Microarray
Microarray hybridizations were performed in triplicate for each of the
experimental groups using Affymetrix Bovine DNA Chips as described by the
manufacturer (Affymetrix Santa Clara, CA). Briefly, complementary DNA (cDNA)
synthesis was performed from 10 ng total RNA using the Two-Cycle cDNA Synthesis
Kit (Affymetrix Santa Clara, CA). The MEGAscript® T7 Kit (Ambion, Inc.) was used
for the first in vitro transcription (IVT). GeneChip IVT Labeling Kit was used for the
second IVT and labelling of RNA. Complementary RNA (cRNA) was fragmented and 10
μg of fragmented cRNA were hybridized to the Genechips in a Hybridization Oven, set to
45°C and rotations of 60 rpm for 16 hours. The chips were then washed and stained with
streptavidin/phycoerythrin (SAPE) antibody solution using an Affymetrix FS-450 fluidics
station. GeneChips were scanned using the Affymetrix GeneChip scanner 3300.
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3.3.7 Microarray Data Processing
Images were processed with the Affymetrix GeneChip® Operating Software
(GCOS) and expression quantified with MAS 5.0, which also provides information on
signal, detection and calculated the detection p-value. Signal information is a numeric
value indicating transcript abundance for a particular probe set. Detection information
indicates whether the transcript is detected (P, present), undetected (A, absent), or if it is
at the limit of detection (M, marginal). Detection p-value indicates the significance of the
detection call for a probe set. Only probe sets that were called Present in at least one of
the five groups were included in the analysis. A total of 5,599 probe sets were excluded
from the analysis as they were called Absent in all groups. The data set for further
analysis included 18,396 probe sets.

3.3.8. Hybridization Quality Check
Metrics like noise, background, Scale factor, and the ratio of intensities of 3′
probes to 5′ probes for Actin and GAPDH genes were analyzed for chip quality control.
Spiked in controls (B. subtilis genes lys, phe, thr, and dap) were added to the total RNA
at known concentrations at the beginning of the experiment. Their intensity values were
used to monitor the linear amplification and labeling process. The performance of the
hybridization control genes (E. coli genes BioB, BioC and BioD and P1 Bacteriophage
cre) was also used for determining the quality of each chip.
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3.3.9 Microarray Data Analysis
For data visualization, the raw GeneChip signals were uploaded into GeneTraffic
UNO (Iobion Informatics LLC), which generated scatter plots of pairwise hybridization
comparisons and Heat maps from all hybridizations using hierarchical clustering. Power
Atlas, a web-based resource from the University of Alabama at Birmingham, was used to
estimating the power of the hybridization given the sample size (Page et al., 2006).
HDBStat was used for statistical analysis (Trivedi et al., 2005). Data were quantilequantile normalized and examined for outliers using Person’s correlation. Quality control
statistics included a deleted residuals approach (Chen, 2004; Persson et al., 2005; Trivedi
et al., 2005). False discovery rates (FDR) for the genes were calculated using t-test
(Benjamini et al., 2001). Fold changes were calculated based upon the unadjusted data
means in pairwise comparisons. Probe sets in each pairwise comparison with a p<0.01,
and FDR of <20%, and a Fold Change (FC) in excess of 2.0 were considered to be
significant and examined further. For multiple comparisons, One-way analysis of
variance (ANOVA) from PROC GLM in SAS 9.1 (SAS Institute inc. Carey, NC) was
performed on the complete data set. The Least Significant Difference (LSD) test was
used to detect significant differences between groups.

3.3.10 Gene Ontology Annotation
The probe sets corresponding to differentially expressed genes were uploaded into
the Affymetrix Netaffx Analysis Center (Bovine GeneChip annotation from November 6
2007) to retrieve updated information regarding gene symbol, gene title, Biological
Process (BP), Molecular function (MF), and Cellular Component (CC) (Liu et al.,
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2003a). To complement the annotation from Netaffx, we used the GOAnna tool
(reference) from AgBase, a Mississippi State University curated, web-accessible resource
for functional analysis of agricultural plant and animal gene products (available at
http://agbase.msstate.edu/GOAnna.html). For data visualization, all the GO terms
associated to each gene were uploaded into GOSlimViewer (available at
http://agbase.msstate.edu/GoSlimViewer.html) another AgBase tool that provides a high
level summary of the GO categories found in the dataset allowing a better visualization of
the data.

3.3.11 Data Modeling
Ingenuity Pathway Analysis 5.0 from Ingenuity Systems was used for data
modeling and the analysis of networks related to the generated data sets. Genes
upregulated in IVF embryos compared to CT embryos and donor cells (figure 7) and
genes downregulated in IVF embryos compared to CT embryos and donor cells (figure 8)
were uploaded in the Ingenuity Pathway Analysis 5.0. Since Ingenuity Pathway Analysis
database is based on human, mouse, and rat genes, some of the bovine names were not
recognized by the software, mostly because of different gene symbols. For those genes,
we manually identified the human orthologous symbol.

3.3.12 Real time RT-PCR Gene Expression Analysis
DNA microarray derived gene expression results for genes DNMT3A, DNMT3B,
IGF2R, PLAC8, PGR, BIT1, HMGN3, HSPA1A, NGDN, FBXO9, and GNAI2 were
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confirmed by Real time PCR using GAPDH as the reference gene. Complementary DNA
was generated with the First-Strand cDNA Synthesis system for RT-PCR using
SuperScript III Platinum® Two-Step qRT-PCR Kit (Invitrogen Life Technologies,
Carlsbad, CA) according to the manufacturer’s protocol. The samples were incubated for
10 min at 25°C, 50 min at 42°C and at 85°C for 5 min. Then 2U of E. coli Rnase H was
added to each tube and incubated at 37°C for 20 min. The cDNA was used for
quantitative real-time PCR amplification with SYBR Green I chemistry (Roche Applied
Sciences, Indianapolis, IN). Real-time quantitative PCR was performed using the
LightCyclerTM instrument (Roche Applied Sciences, Indianapolis, IN). The real time
PCR reactions were carried out in a total volume of 10 µl according to the manufacturer’s
manuals for DNA Master SYBR Green I mix (Roche Applied Sciences, IN). The primer
concentrations were adjusted to 0.5 μM for each gene. Primers were designed using
Primer Premier 5 software (Premier Biosoft International, Palo Alto, CA). Primer
sequences used for real time PCR are shown in Table 1. The cycling parameters were 30
seconds at 95°C for denaturation, 50 cycles of 2 seconds at 95°C, 10 seconds at 55°C for
amplification (quantification was performed at this step), and 12 seconds at 72°C for
extension. The specificity of all individual amplification reactions was confirmed by
melting curve analysis. Real-time expression values were calculated through the relative
standard curve method, using 10-fold serial dilutions for both the target and the
endogenous reference genes by measuring the cycle number at which exponential
amplification occurred in a dilution series of samples. Values were normalized to the
relative amounts of the control mRNA, which were obtained from a similar standard
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curve. In real time PCR reactions, the same initial amounts of target molecules were
used, and the Cp values of control mRNA were constant in all samples.

3.3.13 Real time RT-PCR Gene Expression Analysis from Fetal Donor Cells
Donor cell lines included in the study were fibroblasts from non-cloned fetuses
(DC0), and fetal fibroblasts from first, second, fourth, and fifth rounds of cloning (DC1,
DC2, DC4, and DC5). RNA isolation from donor cells and subsequent cDNA synthesis
were performed according to the above mentioned protocols. Relative mRNA abundance
was determined for paladin (PALLD), nuclear transcription factor Y alpha (NFYA),
glycine amidinotransferase (GATM) and Taspase 1 (C20orf13). Quantitative assessment
of RNA amplification was detected by SYBR® GreenER™ qPCR SuperMixes for
iCycler (Invitrogen Life Technologies, Carlsbad, CA, 11761-100). Real-time PCR
reactions were performed using the iCycler iQ Real-Time PCR instrument (BIO-RAD).
The cycling parameters were 50°C for 2 min, 95°C for 8 min 30 s for denaturation, 40
cycles of 15 s at 95°C and 30 s at 60°C and 30 s at 72°C for amplification and extension
respectively. The melting curve was performed starting at 55°C with a 0.5°C increase for
10 s in 80 cycles. Expression values were calculated using the relative standard curve
method. Standard curves were generated using 10-fold serial dilutions for both GAPDH
and 18S ribosomal RNA. Standard curves were also generated for all target genes by
measuring the cycle number at which exponential amplification occurred.
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3.3.14 Statistical analysis of Real Time PCR results
Results from different groups were analyzed by one-way analysis of variance
(ANOVA) by SAS 9.1 (SAS Institute inc. Carey, NC). Differences at p<0.001 were
considered significant. An additional analysis was performed using Relative expression
software tool (REST©, 384-beta version May 2005) to compare all samples of each
group. The mathematical model used in the REST software is based on the PCR
efficiencies (E) and the crossing point deviation between the samples (CP) (Pfaffl, 2001;
Pfaffl et al., 2002; Misirlioglu et al., 2006).

3.4 Results

3.4.1 Isolation of Total RNA
The amount of total RNA isolated from pools of 3 embryos was 12.2 ng (between
3.2 and 4.5 ng per blastocyst). RNA integrity ranged from 1.8 to 1.96, based on the ratio
between the 28S and 18S ribosomal RNA bands from the Bioanalyzer gel-like image
(Figure 3.1).

3.4.2 Transcriptome analyses
The Affymetrix GeneChip® Bovine Genome Array contains 24,129 probe sets
representing over 23,998 bovine transcripts, including assemblies from approximately
19,000 UniGene Clusters. In order to assess the influence of the two cycles of linear
amplification, on the representation of original transcripts, we compared microarray
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experiments from one-cycle and two-cycle amplifications using total RNA from DC1.
The results showed that amplification of messages using 1 vs. 2 cycles were highly
consistent with a correlation coefficient of 0.93 (data not shown). These data confirm the
manufacturer’s results using 1 and 2 cycles of linear amplification.
Microarray experiments were performed in three biological replicates for all
blastocysts (CT1, CT4 and IVF) and donor cells (DC1 and DC4). Images were processed
with GCOS and data extracted using MAS 5.0. However, one of the CT1 blastocyst chips
did not pass the quality control analysis (Persson et al., 2005) and was excluded from the
study. The analyses for CT1 are based on the remaining two chips in this group, which
showed an appropriate p-value distribution. The GCOS software expression data report
showed that 56% of the probe sets were called ‘present’ for all donor cell chips. This
number was lower for all blastocyst chips with 44%, 41%, and 47% for IVF, CT1, and
CT4 respectively, suggesting that a lower number of transcripts were present in the
blastocysts. Hierarchical clustering classified all donor cells chips in one single group
indicating small differences in their gene expression profiles. All embryos were classified
in 2 distinctive clusters with IVF blastocysts in one group and all cloned blastocysts in
other group (Figure 3.2).
Pairwise comparisons among all five groups, included only transcripts with a pvalue <0.01, a False Discovery Rate (FDR) of 20%, and a Fold Change >2.0. The
numbers of differentially expressed transcripts in all the pairwise comparisons are
presented in Table 3.1. In general, the number of probe sets that were differentially
expressed between all 3 groups of blastocysts was significantly lower compared to the
number of differentially expressed transcripts between donor cells and embryos (P<0.01).
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This numeric difference alone may indicate a substantial chromatin reprogramming for
blastocysts obtained from first and fourth rounds of cloning. However there were
significantly less differentially expressed transcripts between cloned embryos and donor
cells than between IVF blastocysts and donor cells (P<0.01). Out of 83 differentially
expressed transcripts between both cell lines, 79 corresponded to absent or marginal
signals, leaving only 4 differentially expressed transcripts. Chemokine binding protein 2
(CCBP2) and myocilin, trabecular meshwork inducible glucocorticoid response (MYOC)
were upregulated in DC1 compared to DC4. Similar to hemicentin (LOC528634) and
similar to dolichyl pyrophosphate phosphatase 1 (LOC504908) were the genes
upregulated in DC4 compared to DC1.
Because the bovine genome has not been fully annotated, the annotation
information available from NetAffx Analysis Center (Affymetrix) classifies probe sets as:
1) fully annotated bovine genes; 2) transcripts similar to specific genes, but not
confirmed; 3) hypothetical proteins based on sequence similarity; 4) cDNA clones; and 5)
transcripts with strong, moderate or weak similarity to genes from other species. Table
3.2 presents a breakdown of the differentially expressed transcripts according to these
categories. Only transcripts corresponding to annotated bovine genes were included in
further analyses.
Multiple comparisons through one-way analysis of variance (ANOVA) using a
Bonferronni correction and Least Significant Differences (Gurdon et al.) showed a set of
109 genes that were differentially expressed in the cloned embryos and donor cells
compared to their IVF counterparts. Out of 109 genes, 67 were upregulated in IVF
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embryos compared to CT embryos and donor cells (top 30 in Table 3.3). Forty two genes
were upregulated in CT embryos (top 30 in Table 3.4).

3.4.3 Functional classification of genes
The Gene Ontology (GO) information for each probe set recovered from NetAffx
Analysis Center (Bovine GeneChip November 2007 annotation) was still incomplete for
several probe sets, which lacked annotation for at least one of the three ontologies
Biological Process (BP), Molecular Function (MF), and Cellular Component (CC). The
annotation was complemented with information retrieved using the GOAnna tool part of
the AgBase resource at Mississippi State University. All the GO terms associated to each
gene were uploaded into the AgBase tool GOSlimViewer in order to obtain a high level
summary of the GO categories and create graphs for a better visualization of the data,
determining which classes of gene products are over-represented or under-represented on
each of the three ontologies for cloned embryos compared to IVF embryos.
GOSlimViewer results are summarized in Figures 3.3 through 3.5.

3.4.4 Gene expression analysis by Real Time PCR:
In order to confirm the accuracy of microarray data, the following 11 genes were
selected based on their relevance during embryonic development: DNMT3A, DNMT3B,
IGF2R, PLAC8, PGR, BIT1, HMGN3, HSPA1A, NGDN, FBXO9, and GNAI2. The
expression patterns of the selected genes, obtained by Real time PCR, were consistent
with the results from the DNA microarray analysis (Figures 3.6 trough 3.10).
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The analysis of gene expression in the cell lines showed that both housekeeping
genes, GAPDH and 18S ribosomal RNA, had a similar pattern of expression. The internal
standard 18S ribosomal RNA values were 1.5 times greater in all groups than those of
GAPDH. After normalization based on both housekeeping genes, there were no
differences among the groups for NFYA and Taspase 1 genes. Both G1 and G2 cell lines
had significantly greater concentration of PALLD transcript compared to G0, G4 and,
and G5. For GATM, the transcript levels of G5 were significantly lower than in all of the
other groups (Figure 3.11).

3.4.5 Data modeling
The pathways originated using Ingenuity Pathway Analysis show the most
important pathways in which the differentially expressed genes participate. The top
networks formed by the genes upregulated in IVF embryos compared to both CT groups
included cellular growth and proliferation, embryonic development, cellular assembly
and organization, cellular death and response to stress (Figure 3.12). On the other hand
the networks obtained from the transcripts more abundant in the cloned blastocysts
compared to IVF embryos were cellular morphology cellular development, cell signaling,
and metabolism (Figure 3.13).
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3.5 Discussion

It has been reported that in vitro culture conditions alter gene expression and may
lead to developmental aberrations in IVF derived cattle, commonly referred to as the
large offspring syndrome (Wrenzycki et al., 1999; McEvoy, 2003; Wrenzycki et al.,
2004). In the case of embryos produced by SCNT, besides the alterations due to in vitro
culture conditions, gene expression defects may be caused by improper silencing and
activation of specific genes, altered chromatin remodeling, and epigenetic alterations
(Lazzari et al., 2002). But identifying key genes responsible for the general
developmental failure in cloned embryos is not an easy task, since the alterations may be
caused by a variety of factors including donor cell type, cell cycle stage, nuclear transfer
protocol, source of the oocytes, embryo culture system, embryo transfer procedure,
recipient cows management, and operators’ skills (Oback and Wells, 2007a).
Consequently, there is a big variety of alterations that are not always shared by all cloned
embryos. Still, the common thread uniting many of the SCNT failures can be traced to
epigenetic alterations, specifically failures in chromatin remodeling and DNA and histone
methylation (Vignon et al., 2002; Santos et al., 2003; Suteevun et al., 2006).
Microarray analysis has been used to explore the transcriptome profile of cloned
embryos relative to that of the donor cells and IVF embryos as a control. However, the
appropriate microarray platform is crucial in order to detect changes in particular genes.
Smith and colleagues reported similar transcriptome profiles for cloned blastocysts and
blastocysts produced by artificial insemination (Smith et al., 2005). However, the cDNA
microarray used by Smith and colleagues consisted of placenta and spleen cDNA
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libraries, lacking embryonic genes, which therefore were not analyzed. The results from
the present study show an extensive reprogramming in cloned embryos by the blastocyst
stage. However, the data point to a group of differentially expressed transcripts between
IVF and cloned blastocysts.
Serial cloning is often performed for the production of transgenic animals.
Although apparently healthy animals can be obtained after serial cloning, the efficiency
of cloning decreases from generation to generation despite comparable blastocyst and
early pregnancy rates. This increase in pregnancy losses and perinatal deaths could be
caused by gene expression defects accumulated throughout the serial cloning procedures,
which could be detected in blastocysts, although no phenotypic alterations are observed
at this stage. Furthermore, it has been proposed that the extended culture, associated with
transfection and selection procedures, may induce changes in the donor cells
(Zakhartchenko et al., 2001). To our knowledge this is the first study to focus on the
influence of serial cloning on global transcriptome profile of embryos and donor cells.
Only a small proportion of the data set generated by the present study corresponded to
fully annotated bovine genes (Table 2). The rest of the probe sets were excluded from
further analyses due to lack of annotations. Progress in the annotation of the bovine
genome will greatly facilitate global gene expression studies in the bovine species.
In the present study, multiple comparisons revealed four distinctive patterns of
differential gene expression among all embryos and donor cells. The first pattern
corresponded to genes that had similar expression in IVF embryos and CT embryos, but
had a very different pattern of expression in both donor cell lines. It could be assumed
that these genes completely switched from the “donor cell gene expression mode” to the
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“embryo gene expression mode”. A big proportion of genes in the present study
followed this pattern, including some imprinted and embryonic specific genes such as the
Oct-4 protein coding gene (POU5F1), which has been reported as differentially expressed
for cloned embryos in previous studies (Boiani et al., 2002; Beyhan et al., 2007a).
Placenta specific 8 (PLAC8) also showed this pattern of expression (Figure 5.6). It is
possible that some genes, due to their methylation pattern in the somatic cells or to their
location in the chromosome, are more likely to be reprogrammed by the oocyte factors.
The second pattern corresponded to genes with a similar pattern of expression for
CT embryos and donor cells, and a very different expression pattern in IVF embryos.
These were genes with apparently incomplete reprogramming, still showing a somatic
cell pattern of expression. The heat shock 70 kD protein 1 (HSPA1A), involved in cell
protection from stress and apoptosis was significantly higher in IVF embryos when
compared to CT embryos and donor cells (Figure 5.7 A). Important embryonic genes
showed this pattern of expression. Desmocollin 3 (DSC3) a trans-membrane
glycoprotein, involved in cell adhesion that belongs to the cadherin family, was present in
IVF embryos but was absent in CT embryos and donor cells. The signal transducer and
activator of transcription 3 (STAT3), was significantly upregulated in IVF embryos when
compared to both groups of cloned embryos and donor cells. A similar pattern was
observed for high mobility group nucleosomal binding domain 3 (HMGN3) a gene
involved in chromatin remodeling, a vital process during embryonic genome activation
(Figure 5.7 B). The importance of both genes during morula and blastocyst formation
could make them good candidates in understanding the lower developmental rates of
cloned embryos.
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The third group of genes corresponded to those with a similar pattern of
expression in IVF embryos and donor cells, but with a marked differential expression in
all cloned embryos. Genes over expressed after chromatin transfer could point to a
compensation mechanism. Genes with this kind of expression pattern included
prostaglandin-endoperoxide synthase (PTGS2) and the transcription factor GATA-2.
Both genes had a greater microarray signal in all CT embryos, but low expression in IVF
and donor cells. The imprinted gene glycine amidinotransferase (GATM), showed
significantly greater values in the cloned embryos compared to IVF embryos and donor
cells. Two interesting genes in this group were DNMT3a and DNMT3a transcripts, which
are responsible for de novo methylation. The mRNA abundance was significantly greater
in CT-1 and CT-4 embryos compared to IVF blastocysts (Figure 5.8 A and B). This
pattern of transcription is consistent with the hypermethylation often reported in cloned
blastocysts, which could indicate that de novo DNA methylation occurs on a major scale
in cloned embryos. These results do not agree with previous findings, in which DNMT3A
was downregulated in NT embryos compared to IVF embryos (Beyhan et al., 2007a).
Zhou et al., reported similar levels of DNMT3B for embryos produced in vivo, in vitro,
and by different nuclear transfer methods, including chromatin transfer (Zhou et al.,
2007). These contrasting results confirm that alterations greatly vary and are not shared
by all cloned embryos.
A fourth pattern corresponded to genes that had an increasing or a decreasing
pattern of expression form IVF embryos through donor cells showing an intermediate
pattern of expression in CT embryos. It could be assumed that these genes have been
partially reprogrammed. The imprinted gene insulin-like growth factor 2 receptor
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(IGF2R), one of the most studied genes in the large offspring syndrome, showed similar
expression values in IVF and CT1 embryos, but significantly higher signals in CT4
embryos, and very high signals in both donor cells (Figure 6 F). These higher mRNA
levels in the fourth generation of cloning could indicate a cumulative misregulation of
this gene. The Bcl-2 inhibitor of transcription (BIT1) showed the greatest values in IVF
embryos, intermediate values in CT embryos and the lowest values in donor cells (Figure
6 G). The nuclear transcription factor Y, alpha (NFYA), showed a similar expression
pattern in both IVF and CT1 embryos; although it was significantly lower in CT4
embryos and donor cells. Neuroguidin (NGDN), an eukaryotic translation initiation factor
with important functions in embryonic development was another gene with a decreasing
pattern of expression (Figure 6 H). Genes with and increasing pattern of expression
included F-box protein 9 (FBXO9), and guanine nucleotide binding protein alpha
inhibiting activity polypeptide 2 (GNAI2) represented in Figure 6 I and Figure 6 J,
respectively.
Based on the difference in gene expression for RARB, CRAB1, THBS,
SERPINB5, and HLA-A, Beyhan et al. suggest a possible role for the retinoic acid
signaling pathway in the failures observed in cloned bovine embryos (Beyhan et al.,
2007b). However, the bovine GeneChip does not contain a Retinoic Acid Receptor Beta
(RARB) probe set. It only contains a probe set that corresponds to a bovine EST with
similarity to the rat RARB (Bt.21044.2.A1_at). In the present data, CRAB1 and THBS2
were slightly higher in IVF embryos, although without statistical significance. They also
found differential gene expression among several genes in both donor cells (CDKN1C,
COPG2, DCN, GATM, MEST, NDN, NNAT, PON3, and SGCE). In the current study
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GATM was significantly downregulated in donor cells from the fifth successive
generation of chromatin transfer (Figure 3.9).
At the blastocyst stage there was an extensive reprogramming of cloned embryos
leading to very similar transcriptomes in IVF and CT blastocysts. However, there were
around 200 differentially expressed genes in both CT embryos compared to IVF. For
some genes, the differences were significantly greater in CT4 when compared to CT1,
suggesting a possible cumulative misregulation caused by serial cloning. Genes involved
in transcription, cellular proliferation, embryonic development, cellular death, and
response to stress are over represented in IVF embryos; many of these genes are present
in the nucleus, which was the cell component overrepresented in IVF embryos. Genes
involved in cell morphology, cell development, and metabolism were over expressed in
donor cells and in cloned embryos when compared to IVF, suggesting that they were not
properly silenced in the donor nucleus. The upregulation of genes involved in metabolism
should be further explored as it could be linked to the large size of cloned animals.
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3.6 Conclusions

The present study provides a unique data set for identifying the epigenetic errors
in somatic cloning and may facilitate a better understanding of the reprogramming
process in SCCT. Future studies should involve all of the successive generations of
cloned embryos and their respective donor cells to identify cumulative misregulated
genes. Gene expression studies from fetal, newborn, and placental tissues could identify
genes that are responsible for abnormalities, abortions, stillborns and low birth rate.
As gene expression profile can only show one step in cell phenotype and function
control, namely transcriptome regulation, proteomic analysis could complement this
study by providing a more complete picture of the regulation of embryonic development.
With the advances in bovine genome annotation, more of the differentially expressed
transcripts could be analyzed further providing more information for the currently
unidentified transcripts, which, in the present study represented around 23% of the
dataset. Gene Ontology information for a proportion of the differentially expressed genes
is still incomplete. Thus, for some of the genes the cellular component is known, but the
biological process and/or its molecular function is not documented. It is interesting that
the majority of genes upregulated in CT blastocysts participate in metabolism processes,
while the percentage of metabolism genes in IVF blastocyst was lower compared to
signaling pathway genes.
Our next set of studies will include structural and functional genomics analysis of
genes involved in chromatin remodeling and DNA methylation in bovine. These studies
would provide valuable information regarding the conservation of these proteins in
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mammals, their role in early embryo development, and molecular reprogramming. Some
of these proteins have not been completely annotate and the available information comes
from ESTs or cDNAs. Annotation of genes involved in DNA methylation and chromatin
remodeling in cattle would complement the present study and contribute to our
knowledge of key genes in embryonic development.

Figure 3. 1

Agilent Bioanalyzer gel-like image of total RNA.

Note: The image shows a total RNA gel like-image produced by the Bioanalyzer. (Ten
out of the 15 samples used in the microarray experiment are shown since no more than 11
samples can be run at one time). Lane L: Size markers. Lanes 1 and 2: total RNA from
106 donor cells used for the first round of SCCT. Lanes 3 and 4: total RNA from 106
donor cell used for the fourth round of cloning. Lanes 5 and 6: total RNA from a pool of
3 In Vitro Produced embryos. Lanes 7 and 8: total RNA from a pool of 3 embryos
produced by the first round of chromatin transfer. Lanes 9 and 10: total RNA from a pool
of 3 embryos produced by the fourth round of chromatin transfer. The 28S and 18S
distinctive ribosomal RNA bands are observed for all samples.
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Figure 3.2

Hierarchical clustering of microarray hybridizations.

Note: Cluster analysis of hybridizations and genes performed using GeneTraffic UNO
(Iobion Informatics LLC). All donor cells were clustered in one group, while all the
embryos were clustered in a second group. The embryos clearly separate into two groups:
a group containing the IVF embryos and a group containing the chromatin transfer
embryos.
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Figure 3.3 GoSlimViewer graph of Cellular Component over-represented
terms in IVF and CT embryos.
Note: Sub-cellular locations of gene products found at high levels in both IVF
blastocysts (solid bars) and both groups of CT blastocysts (open bars). The proportion of
genes present in the nucleus was higher in IVF embryos (31%) compared to CT embryos
(5%). There were more membrane and intracellular genes in CT embryos compared to
IVF embryos.
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Figure 3.4 GoSlimViewer graph of Biological Process over-represented terms in
IVF and CT embryos.
Note: Biological processes of gene products found at high levels in both IVF
blastocysts (solid bars) and CT blastocysts (open bars). No genes involved in
development were upregulated in CT blastocysts compared to IVF blastocysts, for which
11% of the genes were involved in development. Conversely a greater proportion of
metabolism genes were overrepresented in CT embryos compared to IVF embryos.
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Figure 3.5 GoSlimViewer graph of Molecular Function over-represented terms in
IVF and CT embryos
Note: Molecular functions of gene products found at high levels in IVF blastocysts
(solid bars) and CT blastocysts (open bars). Genes with receptor function were
higher in IVF blastocysts, while genes with catalytic, signal transduction and
transporter functions were overrepresented in CT blastocysts.
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Figure 3.6 Real Time PCR Validation of PLAC8 transcript abundance.
Note: Gene expression patterns from microarray analysis (solid bars) and relative
quantification through Real time PCR (open bars). Microarray units indicate signal
intensity values. Real time PCR units indicate relative expression to the internal standard
GAPDH. Different letters on top of each bar indicate significant differences in expression
(P <0.01).
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Real Time PCR Validation of HSPA1 and HMGN3 transcript
abundance.

Note: Gene expression patterns from microarray analysis (solid bars) and relative
quantification through Real time PCR (open bars). Microarray units indicate signal
intensity values. Real time PCR units indicate relative expression to the internal standard
GAPDH. Different letters on top of each bar indicate significant differences in expression
(P <0.01).
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Figure 3.8 Real Time PCR Validation of DNMT3a and DNMT3b transcript
abundance.
Note: Gene expression patterns from microarray analysis (solid bars) and relative
quantification through Real time PCR (open bars). Microarray units indicate signal
intensity values. Real time PCR units indicate relative expression to the internal
standard GAPDH. Different letters on top of each bar indicate significant differences in
expression
(P <0.01).
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Figure 3.9 Real Time PCR Validation of IGF2R, FBXO9, and GNAI2
transcript abundance.
Note: Gene expression patterns from microarray analysis (solid bars) and relative
quantification through Real time PCR (open bars). Microarray units indicate signal
intensity values. Real time PCR units indicate relative expression to GAPDH. Different
letters on top of each bar indicate significant differences in expression (P <0.01).
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Figure 3.10 Real Time PCR Validation of BIT1, NGDN, and PGR transcript
abundance.
Note: Gene expression patterns from microarray analysis (solid bars) and relative
quantification through Real time PCR (open bars). Microarray units indicate signal
intensity values. Real time PCR units indicate relative expression to GAPDH. Different
letters on top of each bar indicate significant differences in expression (P <0.01).
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Real Time PCR Validation of PALLD, NFYA, GATM and Taspase1
in cells lines obtained from serial cloning.

Note: Cell lines derived from 0 rounds of cloning (G0) first round of cloning (G1),
second round of cloning (G2), fourth round of cloning (G4), and fifth round of cloning
(G5). Units indicate relative expression to the internal standards GAPDH and 18S rRNA.
Different letters indicate significant differences in expression between different donor
cell lines (P<0.01).

73

Figure 3.12

Network of genes with high expression levels in IVF embryos.

Note: Data modeling of genes with high expression in IVF embryos compared to cloned
embryos. The top networks in the pathway include cellular growth and proliferation,
embryonic development, cellular assembly and organization, cellular death and response
to stress and cancer.
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Figure 3.13

Network of genes with high expression levels in NT embryos.

Note: Data modeling of genes with high expression in CT embryos compared to IVF
embryos. The top networks in the pathway include cellular morphology, cellular
development, cell signalling and metabolism.
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Table 3.1

Number of differentially expressed transcripts in microarray pairwise
comparisons.

Comparison
Group 1 vs. Group 2

Differentially

Higher in the

Higher in the

expressed

first group

second group

transcripts

1

IVF embryos vs. CT-1 embryos

270 a

123

147

2

IVF embryos vs. CT-4 embryos

411 a

193

218

3

IVF embryos vs. DC-1 cells

3360

c

1548

1812

3428

c

1593

1835

91

101

4

IVF embryos vs. DC-4 cells

a

5

CT-1 embryos vs. CT-4 embryos

193

6

CT-1 embryos vs. DC-1 cells

2459 b

1238

1221

7

CT-1 embryos vs. DC-4 cells

2588

b

1379

1209

2036

b

1151

885

2276

b

1287

989

34

49

8

CT-4 embryos vs. DC-1 cells

9

CT-4 embryos vs. DC-4 cells

10

DC-1 cells vs. DC-4 cells

83 d

Comparisons were performed between a pair of groups IVF embryos, CT1 embryos, CT4
embryos, DC1 cells, and DC4 cells. (p-value <0.01 and fold change <2.0).
Different subscripts indicate statistically significant differences in the number of
differentially expressed transcripts.
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Table 3.2

Classification of differentially expressed probe sets in pairwise
comparisons.
Comparisons

Probe set category
Genes
"Similar to…
Hypothetical proteins
cDNA clones
Transcripts with strong
similarity to a known gene
Transcripts with moderate
similarity to a known gene
Transcripts with weak
similarity to a known gene
Unknown transcripts
Total

CT4
vs.
DC1

CT4
vs.
DC4

DC1
vs.
DC4

CT1
vs.
DC1

CT1
vs.
DC4

44
81
0
0

574
1071
69
19

563
1132
80
16

421
898
65
17

461
995
76
16

23
34
6
0

23

0

17

17

19

21

0

24

27

2

13

16

12

14

2

13
872
3360

15
873
3428

1
64
192

10
686
2459

17
747
2588

8
596
2036

10
683
2276

0
18
83

IVF
vs.
CT4

IVF
vs.
DC1

IVF
vs.
DC4

63
106
4
0

104
180
10
1

747
1564
90
24

763
1597
102
28

1

3

26

2

0

1
93
270

0
113
411

IVF
vs.
CT1

CT1
vs.
CT4

The probe set categories correspond to NetAffx Bovine GeneChip (Annotation,
November 2007).
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Table 3.3

Top 25 upregulated genes in IVF blastocysts compared to CT blastocysts.
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Probe set ID
Bt.28010.1.S1_at
Bt.21013.1.S1_at
Bt.28223.1.S1_at
Bt.9525.1.A1_at
Bt.2892.1.S1_at
Bt.4430.1.S2_at
Bt.5154.1.S1_at
Bt.15787.1.S1_at
Bt.13544.2.S1_a_at
Bt.2005.1.S1_at
Bt.16291.1.A1_at
Bt.27854.1.S1_at
Bt.13928.2.S1_a_at
Bt.15334.2.A1_at
Bt.12506.1.S1_at
Bt.20204.1.S1_at
Bt.20199.1.A1_at
Bt.3359.1.S1_at
Bt.2958.1.A1_at
Bt.3002.1.S1_at
Bt.6087.1.S1_at
Bt.4737.1.S2_s_at
Bt.1854.1.S1_at
Bt.5340.1.S1_s_at
Bt.8.1.S1_at

Gene Title
Peptidase inhibitor 3, skin-derived (SKALP)
Polo-like kinase 3 (Drosophila)
20-beta-hydroxysteroid dehydrogenase-like
Zinc finger protein 183
Fatty acid binding protein 7, brain
ATPase, H+ transporting, lysosomal V0 subunit a1
Heat shock 70kDa protein 1A
Bcl-2 inhibitor of transcription
Zinc finger protein 410
LSM1 homolog, U6 small nuclear RNA associated
Testis expressed 12
Nuclear factor, interleukin 3 regulated
Sodium channel modifier 1
Signal transducer and activator of transcription 3
Serpin peptidase inhibitor, E member 2
Sjogren's syndrome/scleroderma autoantigen
DEAD (Asp-Glu-Ala-Asp) polypeptide 56
General transcription factor IIF, polypeptide
Ubiquitin-conjugating enzyme E2A (RAD6 homolog)
BUB3 budding uninhibited by benzimidazoles 3
Transmembrane 4 superfamily member 1
Prion protein
Intraflagellar transport 20 homolog (Chlamydomonas)
Nucleoside-diphosphate kinase NBR-A
Keratin 10 (epidermolytic hyperkeratosis)

Gene ID
PI3
PLK3
MGC127133
ZNF183
FABP7
ATP6V0A1
HSPA1A
BIT1
ZNF410
LSM1
TEX12
NFIL3
SCNM1
STAT3
SERPINE2
SSSCA1
DDX56
GTF2F1
UBE2A
BUB3
TM4SF1
PRNP
IFT20
NBR-A
KRT10

P value
0.000000
0.000001
0.000009
0.000057
0.00014
0.00014
0.0002
0.0002
0.0003
0.0003
0.0004
0.0004
0.0004
0.0005
0.0005
0.0005
0.0006
0.0009
0.001
0.001
0.001
0.001
0.001
0.002
0.002

Genes were analyzed by one-way ANOVA and sorted by P-value. FC: Fold Change
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FC
IVF/CT1
5.58
3.99
2.13
2.13
1.22
1.89
4.14
1.49
2.01
1.86
3.40
1.72
2.02
4.71
1.52
1.61
1.45
1.53
2.03
1.27
2.29
2.20
1.65
1.42
1.98

FC
IVF/CT4
9.12
9.09
1.71
3.62
6.35
1.93
7.17
2.01
1.90
1.57
3.64
3.08
4.05
16.06
1.42
2.93
1.79
1.98
3.08
1.62
6.62
2.99
2.30
1.76
3.39

Table 3.4

Top 25 upregulated genes in CT blastocysts and donor cells compared to IVF blastocysts.
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Probe set ID
Bt.8933.1.S1_at
Bt.27382.1.A1_s_at
Bt.22224.1.S1_at
Bt.3220.1.S1_at
Bt.7805.2.S1_a_at
Bt.29540.1.S1_at
Bt.19690.1.A1_at
Bt.20444.1.S1_at
Bt.16122.1.S1_at
Bt.5737.1.S1_at
Bt.4292.1.S1_at
Bt.18230.1.S1_a_at
Bt.9107.1.S1_a_at
Bt.663.1.S1_at
Bt.1743.2.S1_a_at
Bt.13205.1.A1_at
Bt.25100.1.A1_at
Bt.783.1.S1_at
Bt.23608.1.S1_s_at
Bt.27284.1.S1_at
Bt.10898.1.S1_at
Bt.28745.1.S1_at
Bt.5267.1.S1_at
Bt.355.1.S1_at
Bt.20084.2.S1_at

Gene Title
Adaptor-related protein complex 3, sigma 2
X-ray repair complementing defective repair in Chinese hamster cells 1
insulin receptor substrate 4
Crystallin, lambda 1
Nuclear casein kinase and cyclin-dependent kinase substrate 1
Arginine/serine-rich coiled-coil 1
Paraoxonase 1
thyroid hormone receptor associated protein 5
Sorbitol dehydrogenase
vacuolar protein sorting 26 homolog A
ARP3 actin-related protein 3 homolog (yeast)
Nuclear autoantigenic sperm protein
phosphatidylinositol binding clathrin assembly protein
Palladin, cytoskeletal associated protein
Phenylalanyl-tRNA synthetase 2, mitochondrial
Mitochondrial ribosomal protein S35
Cortactin
Aldehyde oxidase 1
Keratin 8
Eukaryotic translation initiation factor 4H isoform 2
Tumor differentially expressed 2-like
Coagulation factor II receptor-like 1
Annexin A6
Caldesmon 1
Casein kinase 1, epsilon

Gene ID
AP3S2
XRCC1
IRS4
CRYL1
NUCKS1
RSRC1
PON1
THRAP
SORD
VPS26
ACTR3
NASP
PIBCAP
PALLD
FARS2
MRPS35
CTTN
AOX1
KRT8
WBSCR1
TDE2L
F2RL1
ANXA6
CALD1
CSNK1E

Genes were analyzed by one-way ANOVA and sorted by P-value. FC: Fold Change
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P value
0.0001
0.0001
0.0002
0.0003
0.0003
0.0004
0.0005
0.0006
0.0008
0.0008
0.0008
0.0011
0.0014
0.0019
0.0021
0.0023
0.0026
0.0029
0.0030
0.0038
0.0041
0.0045
0.0046
0.0047
0.0053

FC
CT1/IVF
1.61
2.60
2.31
1.94
3.14
1.57
1.53
1.60
2.59
2.33
1.69
1.95
1.83
2.88
1.64
1.44
1.26
1.99
3.99
2.21
1.98
2.25
1.92
1.71
3.90

FC
CT4/IVF
2.21
2.54
2.10
1.82
3.47
3.09
3.74
1.20
3.40
3.38
1.69
2.75
2.93
3.08
2.98
2.29
1.58
3.67
4.59
1.55
5.08
1.85
3.79
1.79
2.64

Table 3.5 Primers used for Real time PCR validation

Genes

Primer sequences and positions (5’ - 3’)

GAPDH_F

TGCTGGTGCTGAGTATGTGGT

(333-354)

GAPDH_R

AGTCTTCTGGGTGGCAGTGAT

(627-648)

DNMT3A_F

CTGGCTCTTTGAGAATGTGGTG

(2372-2394)

DNMT3A_R

TCACTTTGCTGAACTTGGCTATT

(2607-2630)

DNMT3B_F

GGGAAGGAGTTTGGAATAGGAG

(698-720)

DNMT3B_R

CTCTGGTTGCTTGTTGTTAGGTT

IGF2R_F

AACCAGGTGATTTAGAAAGTGCC (1939-1962)

IGF2R_R

CGCTTCTCGTTATTGTAGGGTG

(2335-2357)

PLAC8_F

TGTTTCACAGCCAGGTTACAGC

(168-190)

PLAC8_R

GGGTCCGATACATTGTCCTCAT

(367-389)

PGR_F

TAAATGACCAGCAAGCAGAAACT

(562-585)

PGR_R

GGTAATTGTGCAGCAATAACCTC

(955-978)

BIT1_F

CGGAGCCAGAGGAAGAATGA

BIT1_R

TGCTTGTAGGCAGAAACAGCA

HMGN3_F

GTTCCAGCCCGTTGCTTTAC

HMGN3_R

GACCATTCATTCTCCCTCGTTAG

HSPA1A_F

CACGATGTTGATCCTGTGGG

HSPA1A_R

CACCTTAGGCTTGTCTCCGTC

(465-487)

NGDN_F

GTGAGAATGACCCACTCCGTT

(403-424)

NGDN_R

TCCCGCTTGCTGACACTTAA

(799-819)

FBXO9_F

GCAGACGGCAGGAGTAGACAC

(231-252)

FBXO9_R

ACAAGTTGCATAGCCCTACGAT

(675-697)

GNAI2_F

TCCAGACAACTGCCAACATCA

GNAI2_R

CAAACCAGGTGAACAATTCCATA (2192-2215)

PALLD_F

AGGTTGACCTACGAGGAAAGGA (2071-2092)

PALLD_R

ATGTGAACGTCGCAGGCATA

NFYA_F

CGGGCTAAATTAGAAGCAGAAG

NFYA_R

AGGGCAGAATGTGATCGTCAG

GATM_F

ATTGGCTGCTCAGGGAAAGT

GATM_R

ACATGGTCGGTCAGGGTTG

TASPASE1_F

CAAGACTCATATTTCCAGACTCCC (1145-1169)

TASPASE1-R

CCAAGCACTAACTACAGCAGCAC (1408-1431)

(1114-1137)

(75-95)
(519-530)
(22-42)
(376-399)
(86-106)

(1978-1999)

(2362-2382)
(998-1020)
(1308-1329)
(824-844)
(1085-1104)
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Fragment
size (bp) Accession Number
295

XM_865742

236

XM_867643

417

NM_181813

397

NM_174352

200

NM_001025325

394

XM_613908

445

NM_001034519.1

355

NM_001034504.1

380

NM_174550.1

397

NM_001046459

445

NM_001034412.1

215

XM_589440.3

292

XM_869983.2

311

NM_001014956.1

262

NM_001045878.1

264

NM_001034577.1

CHAPTER 4
COMPARATIVE FUNCTIONAL GENOMICS OF MAMMALIAN
DNA METHYLTRANSFERASES

4.1 Abstract
As an essential element of the epigenome, mammalian DNA methylation is
catalyzed by the DNA methyltransferases (DNMTs). These enzymes play a crucial role
in regulation of gene expression in disease and development.
Three mammalian DNMT’s (DNMT1, DNMT3A and DNMT3B), together with the
accessory protein DNMT3L, are responsible for the acquisition of specific DNA
methylation patterns during gametogenesis, embryogenesis and somatic tissue
development. There is no consensus on DNA methylation activity of DNMT2, however,
this enzyme has recently been shown to catalyze methylation of tRNAAsp. The present
study focuses on structural and functional genomics analysis of cattle DNMT’s
comparing them to the humans and mice proteins. Our previous studies have shown
greater mRNA abundance of DNMT3a and DNMT3b in cloned embryos. Therefore, we
also wanted to establish the patter of expression of these enzymes during embryogenesis
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to improve our understanding of epigenetic regulation in early mammalian development.
Our findings showed a high degree of structural and functional conservation among the
human, mouse, and bovine DNMT’s. In addition, our results showed similar patterns of
transcript abundance for all of the proteins at different stages of early embryo
development. A predicted protein sequence for bovine DNMT3L is available
(XP_869990.2), i.e., its RNA or protein has not been confirmed yet. Remarkably, all of
the DNMTs with an important role in DNA methylation (DNMT1, DNMT3A, DNMT3B,
and DNMT3L) show greater degree of structural similarity between human and bovine
than that between human and mouse. These results have important implications for the
selection of an appropriate model for study of DNA methylation during early
development in humans.

4.2 Introduction
Regulation of gene expression without any actual modification of DNA sequence,
epigenetics, is a topic that has garnered increasing attention in the post-genomic era.
Epigenetic regulation causes differential expression of genes depending on the type of
tissue and stage of development. DNA methylation is a well-studied epigenetic process
with a variety of key roles in gene repression (Nan et al., 1998; Beaujean et al., 2004),
control of cellular differentiation (Shin et al., 2002; Ehrlich, 2003a), gene regulation
during embryonic development (Okano et al., 1999; Shiels et al., 1999; Reik et al., 2001),
X chromosome inactivation, and genomic imprinting (Shin et al., 2002; Chow and
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Brown, 2003). Other important roles of DNA methylation include silencing of
endogenous retroviruses, suppression of homologous recombination, and protection from
the mutagenic effects of the abundant transposable elements in mammalian genomes
(Yoder et al., 1997; Bestor, 2000). DNA methylation results from the activity of a family
of enzymes called DNA methyltransferases (DNMT’s) that catalyze the addition of a
methyl group to the cytosine residues at CpG dinucleotides (Nan et al., 1998). Four
different DNA methyltransferases have been identified and their structure as well as
functions have been extensively reviewed (Kumar et al., 1994; Bestor, 2000; Hermann et
al., 2003). These DNA methyltransferases are widely conserved among different species.
Mammalian DNMT’s contain at least three structural regions: the N-terminal regulatory
domain, which is responsible for the localization of DNMT’s in the nucleus, the Cterminal catalytic domain, which is responsible for the methyltransferase activity, and the
central linker, consisting of repeated GK dipeptides (Araujo et al., 2001). The regulatory
N-terminal domain contains a proliferating cell nuclear antigen-binding domain (PBD), a
nuclear localization signal (NLS), a cysteine-rich zinc finger DNA-binding motif
(ATRX), a polybromo homology domain (PHD), and a PWWP tetrapeptide chromatinbinding domain (Bestor, 2000). The C-terminal DNMT’s catalytic domain contains ten
different characteristic sequence motifs, six of which are evolutionally conserved: I, IV,
VI, VIII, IX, and X (Turek-Plewa and Jagodzinski, 2005).
The first identified DNA methyltransferase, DNMT1, plays a key role in
maintenance of DNA methylation by restoring the methylation pattern on newly
synthesized hemi-methylated DNA strands during replication (Bestor et al., 1992;
Pradhan et al., 1999). An interesting DNMT1 isoform lacking 118 amino acids from the
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N-terminal domain (DNMT1o) is exclusively active in oocytes and preimplantation
embryos and is later replaced by the regular somatic DNMT1 (Bestor, 2000). DNMT2,
the smallest mammalian DNMT, contains only the methyltransferase motifs of the Cterminal domain, and, although it is highly conserved, its biological function has been
enigmatic (Yoder and Bestor, 1998; Dong et al., 2001). Some studies show that DNMT2
acts as a DNA methyltransferase (Kunert et al., 2003) while other studies have detected
little DNA methylation activity. Recent research has demonstrated that DNMT2
methylates tRNAAsp in the cytoplasm (Goll et al., 2006; Rai et al., 2007). DNMT3a and
DNMT3b are similar proteins that have been identified as de novo DNA
methyltransferases acting upon hemi-methylated and unmethylated DNA with equal
efficiency during early embryonic development and gametogenesis (Okano et al., 1998;
Okano et al., 1999). The DNA cytosine-like 5-methyltransferase (DNMT3L) protein
lacks the most important C-terminal methyltransferase motifs, but possesses an active
nuclear localization signal sequence (NLS) and the ATRX zinc finger motif, (identical to
the ones in DNMT3A and DNMT3B enzymes) that enable nucleus translocation and
DNA binding. DNMT3L has a PHD-like motif that activates Histone deacetylase 1
(HDAC1) (Deplus et al., 2002; Turek-Plewa and Jagodzinski, 2005) and has recently
been shown to also recognize histone H3 tails that are unmethylated at lysine 4 and
induce de novo DNA methylation by recruitment or activation of DNMT3A (Ooi et al.,
2007). Thus, DNMT3L has a dual role in de novo DNA methylation, interacting with
unmethylated lysine 4 of histone H3 through its PHD-like domain while interacting and
activating DNMT3A through its carboxy-terminal domain (Jia et al., 2007).
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Modulation of DNA methylation early embryogenesis is dynamic and
developmentally regulated. Genomewide DNA demethylation, with the exception of
methylation marks at imprinted genes, occurs during the first embryonic stages (Oswald
et al., 2000; Reik et al., 2001). The paternal genome is significantly and actively
demethylated within hours of fertilization, before the onset of DNA replication, whereas
the maternal genome is demethylated after several cleavage divisions (Mayer et al.,
2000). This demethylation is followed by de novo DNA methylation that establishes a
new embryonic methylation pattern. The DNA of blastocysts is thus relatively
undermethylated. The exact biological function of this dynamic reprogramming of DNA
methylation in early development is unknown. Several studies support the hypothesis that
DNA methylation is crucial for the establishment of gene expression during embryonic
development (Eden and Cedar, 1994; Jones et al., 1998). However, recent data suggest
that DNA methylation may only affect genes that are already silenced by other
mechanisms in the embryo, indicating that DNA methylation could be a consequence
rather than a cause of gene silencing during development (Nan et al., 1998; Walsh and
Bestor, 1999; Bestor, 2000; Szyf, 2005a).
The objectives of the present study were to determine the structural and functional
conservation among DNA methyltransferases of human, mouse, and bovine as means of
better understanding the role of these enzymes in epigenetic regulation during early
mammalian embryonic development. Additionally we intended to improve the gene
annotation of bovine DNMT’s, for which annotation was incomplete. Our study confirms
a high degree of conservation in the protein sequences and functional domains among the
studied species. Although mouse is routinely used as a model for mammalian embryonic
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development, our results showed that bovine and human DNMTs all have much higher
similarities than the mouse and human DNMTs. This difference is especially striking for
DNMT3L that has recently been shown to have dual roles in de novo methylation of
DNA. These results have important implications for the selection of appropriate models
to study mammalian DNA methylation during embryogenesis.

4.3 Materials and Methods
The nucleotide and protein reference sequences for mouse, human, and bovine
DNMT’s (DNMT1, DNMT2, DNMT3A, DNMT3B, and DNMT3L) were obtained from
NCBI (see Table 4.1).

4.3.1 Structural analyses of DNMTs
Pairwise visual sequence comparisons were performed using dot matrix alignment of the
protein reference sequences. The comparisons were generated for each DNMT for mouse
vs. human, mouse vs. cow, and human vs. cow using the on-line dottup tool from the
European Molecular Biology Open Software Suite EMBOSS using a word size of 10
(http://emboss.bioinformatics.nl/cgi-bin/emboss/dottup). A solid diagonal line indicates
sequence similarity. A break in the line with a shift indicates an insertion or a deletion in
one of the sequences. A gap indicates low similarity.
Pairwise sequence similarity was computed for the mouse, human, and bovine
sequences using the GAP program (Huang X, 1991) with Blosum62 as the scoring matrix
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and the following alignment parameters: match 11, mismatch -4, gap-open penalty 10,
and gap-extension penalty 2. The program is available from Michigan Tech University
(http://genome.cs.mtu.edu/align/align.html). Multiple sequence alignments for mouse,
human and bovine DNMTs were done using both ClustalW (Chenna et al., 2003) and TCoffee (Notredame et al., 2000) available on-line from the European Bioinformatics
Institute (http://www.ebi.ac.uk/clustalw) using the Gonnet scoring matrix, a gap-open
penalty of 10, and gap-extension penalty of 0.5. High level views of multiple sequence
alignments and conserved domains were generated using in-house software that is part of
the MSAVIS package (Lindeman et al., 2007).
Phylogenetic trees for the DNMTs were generated using the sequences listed in
Table 4.3 with chicken used as the out-group for drawing the trees for all proteins except
for DNMT3L, where opossum was used as the out-group. Multiple sequence alignments
were generated using T-Coffee with the parameters listed above. Phylogenentic trees
were generated using both neighbor joining and maximum likelihood methods
implemented in the Phylip program (Felsenstein, 2005). Phylip programs used to
generate the trees were PROTDIST, NEIGHBOR, PROMLK, SEQBOOT, and
CONSENSE. The distance matrix for neighbor joining was computed using the JTT
model (Jones et al., 1992). The molecular clock assumption was tested using a procedure
described by Tuimala in 2006 (Tuimala, 2006). Because the assumption of a molecular
clock was rejected with p=0.05 for DNMT1 and DNMT3b, but not for DNMT2 and
DNMT3a, we used PROML (no molecular clock) for all phylogenetic analyses. The ML
program PROML was run with the iterative search option (s) and with the global search
(g) option for subtree pruning and regrafting to improve the quality of the tree. The
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consensus trees were inferred from 250 bootstrap replications for the ML and NJ
methods. Trees generated by the two methods were similar and ML trees are shown in the
results since this method is generally considered to be more accurate and the branches in
the ML trees had higher bootstrap values than those in the NJ trees. Trees were drawn
using the online Interactive Tree of Life (iTOL) tool (Letunic and Bork, 2007).

4.3.2 Annotation of genes involved in DNA methylation
Annotations of DNMT2, DNMT3b and DNMT3L were performed using the
Apollo software, an interactive tool that enables gene annotators to inspect
computationally obtained gene predictions, and edit them by evaluating all the data
supporting each annotation (Lewis et al., 2002). Apollo was successfully used to annotate
the Drosophila melanogaster genome (Drysdale, 2003), and was the tool recommended
by the Bovine Genome Sequencing Consortium for manual annotation of bovine genes.
Each gene was uploaded to Apollo by specifying its region on the chromosome,
(scaffold), by using the BLAST tool at BovineGenome.org to identify the official gene
model (GLEAN) and its location. Apollo software was used to confirm the protein
sequence accuracy by translating the DNA and identifying untranslated region (UTR),
translation start, exons, introns, and translation stop. Previous protein information from
NCBI or Ensembl, was compared to the GLEAN sequence and errors in the proteins were
analyzed in detail. Annotations were submitted to the Bovine Genome Annotation
Submission Database at BovineGenome.org.
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4.3.3 Functional Analyses of DNMTs
Protein sequences were analyzed using the conserved domain database (CDD) at
the NCBI website (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). The program
imports multiple sequence alignments from SMART (Simple Modular Architecture
Research Tool), Pfam (Pfam-A seed alignments from the Protein families database of
alignments and HMMs), and COGs (Clusters of Orthologous Groups of proteins). Which
are used to compare the amino acid sequences in the query protein to sequences with
known domains (Marchler-Bauer et al., 2005).

4.3.4

Determination of DNMT transcript abundance

4.3.4.1 In vitro maturation, fertilization and culture of embryos
Oocytes were collected from 2-8 mm follicles of bovine ovaries obtained from a
local slaughterhouse. Only oocytes containing several layers of cumulus cells and
homogenous cytoplasm were selected. Oocytes were washed three times in TL-HEPES
before transferring into maturation media. The maturation medium used was Tissue
Culture Medium (TCM) 199 (Gibco/Invitrogen) supplemented with 0.2 mM pyruvate,
0.5 µg/ml follicle-stimulating hormone (FSH; Sioux Biochemicals, Sioux City, IA,
USA), 5 µg/ml luteinizing hormone (LH; Sioux Biochemicals), 10% fetal calf serum
(FCS, Gibco/Invitrogen), 100 U/ml penicillin and 100 mg/ml streptomycin
(Gibco/Invitrogen). Ten oocytes in each 50 µl maturation drop were covered with mineral
oil and incubated for 24h at 39C° in a humidified incubator with 5% CO2 (Misirlioglu et
al., 2006). After 24 hours, mature oocytes were washed twice with TL-HEPES. Mature
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oocytes were randomly selected for either RNA isolation or fertilization. Pools of 100
oocytes were frozen at -80°C on RLT lysis buffer (Qiagen Valencia, CA) until RNA
isolation.
For fertilization, groups of 10 oocytes washed with TL-HEPES were transferred
into 44 µl drops of fertilization medium (glucose-free TALP supplemented with 0.2 mM
pyruvate, 6 mg/ml fatty acid-free BSA, 100 U/ml penicillin and 100 mg/ml
streptomycin). Percoll gradient was used for separation of live spermatozoa in frozenthawed semen (Misirlioglu et al., 2006). Briefly, sperm was thawed at 36°C for 1 min,
and then carefully layered on top of the Percoll gradient system. Sperm was diluted in LHEPES to 5.0 x107 cells/ml and 2 µl of diluted sperm were added to the 44 µl
fertilization drops, which produced a final sperm concentration of 2.0 x106 cell/ml.
Fertilization was completed by adding 2 µl of 5 µg/ml heparin, and 2 µl PHE solution (20
mM penicillamine, 10mM hypotaurine, 1 mM epinephrine) and co-culture of oocytes and
sperm for 18h in the incubator (Leibfried and Bavister, 1982).
After 18 hours, cumulus cells were removed from oocytes by vortexing in a 1.5
ml Eppendorf tube for 3 min. Presumptive zygotes were washed three times by TLHEPES and transferred into 50 µl culture drops of SOF under mineral oil (25 zygotes per
drop). At 48 hours post in (hpi), cleavage rate (proportion of zygotes that reached the 2cell stage) was recorded and 2-cell embryos were randomly selected for RNA isolation or
further development. Pools of 100 2-cell stage embryos were frozen at -80°C on RLT
lysis buffer (Qiagen Valencia, CA) until RNA isolation. Embryos selected for further
development were kept under the same cultured conditions.
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At 96 hpi, the proportion of embryos reaching the 8- cell stage was recorded and
8-cell stage embryos were randomly selected for RNA isolation or further development.
Pools of 100 8-cell embryos were frozen at -80°C on RLT lysis buffer (Qiagen Valencia,
CA) until RNA isolation. Embryos selected for further development were kept under the
same cultured conditions. Five µl of FCS was added into each culture drop.

4.3.4.2 Isolation of RNA
Total RNA was isolated from pools of 100 oocytes, 100 2-cell embryos, 100 8cell embryos and 10 blastocysts using an RNeasy Micro Kit (Qiagen) according to the
manufacturer’s instructions. Quality of total RNA was estimated using the Bioanalyzer
2100 RNA 6000 picochip kit (Agilent, Palo Alto, CA, USA). RNA quantity and purity
was determined using a NanoDrop® ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, DE). Total RNA from all groups was normalized to 4 ng and
used for cDNA synthesis using SuperScript III Platinum Two Step qRT-PCR kit
according to the manufacturer’s protocol. Cycling temperatures and times were 25°C for
10 min, 42°C for 50 min, and 85°C for 5 min.
4.3.4.3 Real time PCR
Primers were designed using Primer Premier 5 software (Premier Biosoft
International, Palo Alto, CA, USA). All primers were designed to span exon – intron
boundaries to differentiate genomic DNA amplification (Table 3). Complementary DNA
was generated using the SuperScript III Platinum® Two-Step qRT-PCR Kit (Invitrogen
Life Technologies, Carlsbad, CA) according to the manufacturer’s protocol. The samples
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were incubated for 10 min at 25°C, 50 min at 42°C and at 85°C for 5 min. Then 2U of E.
coli Rnase H was added to each tube and incubated at 37°C for 20 min. Real-time
quantitative PCR was performed to assess transcripts of DNMT1, DNMT3a, and
DNMT3b relative to the housekeeping gene GAPDH. Quantitative assessment of RNA
amplification was detected by SYBR® GreenER™ qPCR SuperMixes for iCycler
(Invitrogen Life Technologies, Carlsbad, CA, 11761-100). Five µl cDNA were used for
quantitative Real-time PCR reactions according to the iCycler iQ Real-Time PCR
instrument (BIO-RAD). The primer concentration was adjusted to 10 µM. The cycling
parameters were 50°C for 2 min, 95°C for 8 min 30 s for denaturation, 40 cycles of 15 s
at 95°C and 30 s at 60°C and 30 s at 72°C for amplification and extension respectively.
The melting curve was performed starting at 55°C with 0.5°C increase for 10 s in 80
cycles. Expression values were calculated using the relative standard curve method.
Standard curves were generated using 10-fold serial dilutions for GAPDH and all target
genes by measuring the cycle number at which exponential amplification occurred.
Results from different groups were analyzed by one-way analysis of variance (ANOVA)
by SAS 9.1 (SAS Institute inc. Carey, NC). Relative expression software tool (Whitworth
et al., 2004) was used to compare all samples of each group. The mathematical model
used in the is REST software is based on the PCR efficiencies and the crossing point
deviation between samples (Pfaffl et al., 2002).
Complementary mRNA abundance data for bovine DNMT’s in oocytes and 8 cell
embryos was obtained from a bovine microarray experiment conducted earlier by our
laboratory (Misirlioglu et al., 2006). Expression data for DNMT’s from mouse was
collected from two separate studies (Ratnam et al., 2002; Vassena et al., 2005). Human
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DNMT’s expression data was obtained from Huntriss et al., 2004 (Huntriss et al., 2004)
and the patterns of expression were compared to those of bovine DNMT’s in order to
establish the dynamics of expression of the different enzymes in oocytes and
embryogenesis.

4.4 Results

4.4.1 Structural analyses of DNMTs
Human DNMT2 (also known as TRDMT1) has 3 isoforms. In this study human
isoform “a” and the corresponding isoform for the other two species was used for
alignments. DNMT3a has 2 isoforms in mouse, 3 in humans and 3 in bovines. We used
isoforms corresponding to human isoform a, for the other two species (mouse isoform 1,
and bovine isoform 2). The enzyme DNMT3b has 4 isoforms in humans and mouse and 4
isoforms have also been reported for cattle (Golding and Westhusin, 2003) although they
are not yet available in the databases. The bovine isoform AY244710 corresponds to
human isoform 1. For the present study isoform 1 was used for all species. Complete
information regarding the chromosome, gene, accession numbers, protein lengths, and
isoforms used is summarized in Table 4.1.
All DNMT’s showed a high degree of structural conservation at the protein level.
The protein pairwise sequence alignments for all DNMT’s from the three species (mouse
vs. human, mouse vs. cow and cow vs. human) produced similarity scores however,
human and bovine proteins produced higher similarity scores. These results are
summarized in Table 4.2. Dottup graphs of the pairwise alignments are presented in
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figures 4.1 through 4.15. Solid diagonal lines indicate similar sequences between both
species. Gaps indicate low similarities. As in the pairwise alignments, the human and cow
comparison produced higher similarities. The relatively low similarity of human and
mouse DNMT3L when compared to human and bovine is particularly striking.
Figures 4.16 through 4.20 show the phylogenetic trees generated for DNMTs
from eight mammals, opossum, and chicken. Chicken was used as the outgroup for
drawing all trees except DNMT3L where opossum was used as the outgroup. Rat and
mouse are shown to be more distantly related to human than cow for all enzymes with the
exception of DNMT2. The extraordinary degree of conservation of DNMT3A results in a
very shallow tree indicating that this enzyme is essential for survival and/or development.
Recent results have shown that the C-terminal domains of both DNMT3A and DNMT3L
interact forming a dimmer. The complexed C-terminal domains of DNMT3a and Dnmt3L
further dimerize through a DNMT3a–DNMT3a interaction, forming a tetrameric complex
with two active sites. Both interfaces (DNMT3a–Dnmt3L and DNMT3a–DNMT3a) are
essential for the de novo methylation activity of DNMT3A (Jia et al., 2007). Both
sequence alignment and phylogenetic results indicate that bovine and human DNMT3L
show much greater similarity than mouse and human DNMT3L.

4.4.2 Annotation of genes involved in methylation
Manual annotation of DNMT3b showed that the currently available protein
sequence at the time lacked the C-terminal amino acids due to a missing exon and an
incorrect end codon. The corrected sequence was uploaded to the Bovine Genome
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Annotation submission site. The corrected sequence has been uploaded to NCBI with the
accession number NP_861529.2. Annotation of DNMT2 and DNMT3L showed no errors
in the predicted sequences.

4.4.3 Functional Analyses of DNMTs
All the known mammalian DNMTases have a common structure consisting of a
catalytic C-terminal Cytosine-C5 specific DNA methylase domain. This domain is found
in both prokaryotes and eukaryotes and six of the 10 conserved motifs from prokaryotes
are also conserved in vertebrates. In addition, with the exception of DNMT2, all enzymes
contain a large N-terminal domain that has been identified as having regulatory functions.
Figures 4.21 through 4.25 provide a high level view of the multiple sequence alignment
of the DNMT enzymes with conserved domains from eight mammalian species (7
placental mammals and one marsupial), for which genome sequencing is complete.
4.4.4 Determination of DNMT transcript abundance
Bioanalyzer assessment showed RNA degradation for 2-cell and 8-cell embryos
consistent with the physiological maternal mRNA degradation occurring at these stages.
At the blastocyst stage, total RNA integrity was high as the 28S:18S ribosomal RNA
band ratio was >1.9.
No differences in the levels of DNMT1 mRNA were found among MII, 2-cell,
and 8-cell groups. However, the mRNA level of DNMT1 in the blastocyst group was
significantly lower compared to the other groups. The transcript levels of DNMT3a were
similar between the MII and 8-cell groups, but they were significantly higher in the 2-cell
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and blastocyst groups compared to the oocytes. The transcript levels of DNMT3b were
similar among all the four groups.

4.5 Discussion
The predominant isoform of DNMT1 in somatic cells has 1619, 1616, and 1611
amino acids in mouse, human, and bovine species respectively. A shorter isoform of
Dnmt1, called Dnmt1o, is found specifically in growing oocytes and during early
preimplantation development (Ratnam et al., 2002). Dnmt1o lacks the N-terminal 114
amino acid residues, since its translation initiation lies on exon 4 instead of exon 1.
Dnmt1o displays an increased in vivo stability against degradation and stable ooplasmic
stores of Dnmt1o are available in the oocytes and early embryos.
Parwise comparisons obtained for all of the DNMT proteins for mouse, bovine,
and human species showed a higher sequence similarity between human and bovine than
between mouse and the other two species. The almost complete conservation of
DNMT3A among the three organisms is particularly noteworthy. Multiple sequence
alignments produced using both T-Coffee and ClustalW gave similar alignments.
However, the T-Coffee alignments had fewer gaps and maintained the structure of
conserved domains.
T-Coffee alignments were used as input for Phylip to build the phylogenetic trees.
Golding and Westhusin reported a high level of sequence conservation for DNMT2
among species (Golding and Westhusin, 2003). In the present study, conservation of
DNMT2 sequences among the studied species was comparable to that of DNMT1.
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However, the phylogenetic tree of DNMT2 showed a different branching compared to
that observed for the other DNA methyltransferases, with mouse and rat proteins being
closer to the proteins of primates. The function of DNMT2 in DNA methylation has not
been resolved.
It is sometimes difficult to evaluate structural conservation across a wide range of
mammals including the newly sequenced genomes because of the large number of
predicted protein isoforms. This is particularly true for DNMT1, for which there are 11
predicted isoforms in the chimpanzee, all of which with strong sequence similarities to
human DNMT1, but with deletions or insertions when compared to human isoform a.
Thus for all sequences, we have used the isoform that most closely aligns with the human
isoform listed in Table 1 in our analyses. For some predicted proteins, we have used
manual annotation to correct apparent missed exons and missed translation start sites. For
example, in the predicted DNMT1 protein for rhesus monkey, there is a large deletion
with respect to the chimp and human proteins. The first part of this deletion aligns with
the rhesus genome within the predicted gene on Chromosome 19. A second part of the
deletion matches an unassembled contig. Likewise, some of the predicted proteins, such
as DNMT1 in dog, use a different translation start site than the reference sequences in
other species, although the more typical translation start site is present. In these cases, we
have re-annotated the protein to use the canonical translation start site. Supplemental
Data 1 describes all manual re-annotation and provides both the original and revised
protein sequences.
As expected, all of the DNMTs have high levels of conservation of the
conserved motifs in the C-terminal domain. DNMT1 has an N-terminal domain that binds
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a DMAP-1 transcriptional co-repressor (Rountree et al., 2000), a CXXC zinc finger
domain containing eight conserved cysteine residues that bind to zinc, and two Bromo
Adjacent Homology (BAH) domains. The BAH domain is thought to mediate proteinprotein interaction and to play a role in transcriptional silencing and remodeling of
chromatin (Callebaut et al., 1999). Both DNMT3a and DNMT3b contain a PWWP
domain that is essential for DNMT binding to chromatin (Turek-Plewa and Jagodzinski,
2005) and that is almost completely conserved in all species shown.
According to Carlson et al (Carlson et al., 1992), DNMT1 is expressed
approximately 50,000 fold higher in oocytes as compared to somatic cells. The splice
variant DNMT1o lacks the first 114 N-terminal amino acids and is expressed in mouse
oocytes. Another study shows that mouse Dnmt1o is expressed in oocytes and zygotes
and is later replaced by the complete variant (Ratnam et al., 2002). The Affymetrix
Bovine GeneChips do not include particular probe sets for DNMT1o, therefore it was not
possible to differentiate this variant in our previous microarray experiment, which
showed a 6-fold decrease in DNMT1 transcript abundance in 8-cell embryos compared to
that in MII oocytes (Misirlioglu et al., 2006). However, the sole analysis of mRNA levels
for DNMT1 in pre-implantation embryos may underestimate protein levels, which are
known to be very high in both mature oocytes and embryos (Bestor, 2000). In the present
study, we did not find any significant difference in the levels of DNMT1 transcripts in the
MII oocytes, 2-, and 8-cell embryos. However, the levels of DNMT1 transcripts were
more than 2.5 times lower at the blastocyst stage as compared to the other developmental
stages tested.
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Examination of Dnmt2 mRNA in mouse determined a very low transcript
abundance during earlier embryonic development increasing significantly between the 8cell and morulae/blastocyst stages (Vassena et al., 2005). This pattern of expression
contrasted with that of rhesus monkey and human. In rhesus monkey DNMT2 mRNA
was detected in similar levels from the GV oocyte stage to the morulae stage with a slight
decrease at the blastocyst stage (Vassena et al., 2005). In human, DNMT2 mRNA was
variably detected in MII oocytes and blastocysts (Huntriss et al., 2004). Golding and
Westhusin reported the presence of DNMT2 mRNA in all bovine tissues, being
particularly abundant in adult testis and ovaries. They also detected bovine DNMT2
mRNA at all embryonic stages from the two-cell through blastocyst stage (Golding and
Westhusin, 2003). In our microarray study, DNMT2 transcripts were 10 fold higher in
bovine oocytes compared to 8-cell embryos (Misirlioglu et al., 2006). In other study we
found similar levels of DNMT2 transcripts in bovine fibroblasts and blastocysts (data not
published). These different patterns of DNMT2 mRNA abundance during early
embryonic stages could suggest species specific differences in this enzyme function,
which has been heavily debated in recent years. The available data suggest that DNMT2
has a weak methyltransferase activity on unmodified DNA and RNA. By contrast, the
enzyme activity on a tRNA Asp template seems comparatively strong (Goll et al., 2006),
which might indicate DNMT2 participation in complex nucleic acid modification
pathways.
The previously reported pattern of DNMT3b expression in mouse oocytes and
embryos was reciprocal to that of DNMT3a with low abundance in oocytes and early
embryos, and then a sharp increase in abundance at the blastocyst stage (Vassena et al.,
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2005). In human, DNMT3B was detected continuously from the MII stage oocyte to the
blastocyst stage (Huntriss et al., 2004). In bovine, we reported a similar pattern of
expression for DNMT3a and DNMT3b with an average 3-fold increase in mRNA
abundance in the 8-cell embryos compared to the oocytes (Misirlioglu et al., 2006). In
contrast, the present study did not find significant differences in DNMT3b abundance in
the developmental stages studied and only significantly lower DNMT3a transcripts in
MII oocytes compared to 2-cell embryos and blastocysts. Relative mRNA expression
values are summarized in figure 4.26.
Although DNMT3a and DNMT3b have high structural and functional similarities,
it has been proposed that they have distinct genomic targets and functions (Okano et al.,
1999). In humans, mutations in the DNMT3b gene cause the Immunodeficiency,
Centromeric instability and Facial anomalies syndrome known as ICF. Patients with ICF
have hypomethylated DNA and abnormalities localized mostly to the juxtacentromeric
heterochromatin of chromosomes 1 and 16 (Ehrlich, 2003b). From this syndrome it is
clear that de novo DNA methylation through DNMT3b has an important role in late
immune function and facial phenotype. The role of DNMT3a and DNMT3b is paramount
during embryonic development, yet again at this level functional differences between
both enzyme are evident since DNMT3a deficient mice develop to term and appear
normal at birth, while DNMT3b deficient mice die in utero (Ueda et al., 2006).
One of the functional differences between DNMT3a and DNMT3b could be their
interaction with the enzyme-like protein DNMT3L, which lacks the catalytic domain
common to the DNA methyltransferases. It has been reported that DNMT3L stimulates
de novo methylation by interacting with DNMT3a to (Chedin et al., 2002). Therefore,
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DNMT3L acts as a stimulatory factor for DNA methylation by DNMT3a. This is
particularly true for de novo methylation of imprinted genes in mammalian germ cells
(Jia et al., 2007). Homozygous Dnmt3L mutant male and female mice are viable, but
infertile (Bourc'his et al., 2001; Hata et al., 2002; Hata et al., 2006). Furthermore,
Dnmt3L deficient oocytes showed aberrant methylation of the imprinted genes Small
Nuclear Ribonucleoprotein Polypeptide N (Snrpn), paternally expressed 3 (Peg3) and
insulin-like growth factor 2 receptor (Igf2r) (Lucifero et al., 2007). The level of
interactions between the different DNMT’s has not been fully established yet since
depletion of either DNMT3L or DNMT1o in growing oocytes results in an increase in
DNMT3B, suggesting a potential compensation mechanism by this enzyme, since an
interaction between DNMT3L and DNMT3A is crucial for de novo methylation.
The high degree of structural and functional conservation among the different
DNMT’s, not only within mammals but in all eukaryotes, highlights the importance of
DNA methylation patterns in the regulation of gene expression, particularly at the onset
of development during gametogenesis and embryogenesis. Understanding the complex
interactions between these enzymes and their roles could shed light on the role of
epigenetics in human reproduction and disease. Because of the importance of these
enzymes, it is essential that we identify appropriate models for study of DNA methylation
during early embryonic development.

101

Figure 4.1

Dottup analysis of mouse and human DNMT1 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.2

Dottup analysis of mouse and cow DNMT1 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is low homology in
the initial part of the sequence.
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Figure 4.3

Dottup analysis of human and cow DNMT1 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.4

Dottup analysis of mouse and human DNMT2 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.5

Dottup analysis of mouse and cow DNMT2 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.6

Dottup analysis of human and cow DNMT2 sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.7

Dottup analysis of mouse and human DNMT3a sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a high sequence
similarity
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Figure 4.8

Dottup analysis of mouse and cow DNMT3a sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a high sequence
similarity
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Figure 4.9

Dottup analysis of human and cow DNMT3a sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a high sequence
similarity
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Figure 4.10

Dottup analysis of mouse and human DNMT3b sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion.
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Figure 4.11

Dottup analysis of mouse and cow DNMT3b sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. A deletion of the last part of
the cow sequence is observed.

112

Figure 4.12

Dottup analysis of human and cow DNMT3b sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. A deletion of the last part of
the cow sequence is observed.
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Figure 4.13

Dottup analysis of mouse and human DNMT3L sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a low sequence
similarity for this protein.
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Figure 4.14

Dottup analysis of mouse and cow DNMT3L sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a low sequence
similarity for this protein.
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Figure 4.15

Dottup analysis of human and cow DNMT3L sequence similarities.

Note: Black dots represent identical amino acids. Blank spaces represent different amino
acids. A shift in the line represents an insertion or a deletion. There is a low sequence
similarity for this protein.
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Figure 4.16

Phylogenetic tree of DNMT1.

Note: Chicken was the outgroup for generating the trees. Bootstrap values out of 250
replicates are shown for branches involving mammals.

Figure 4.17

Phylogenetic tree of DNMT2.

Note: Chicken was the outgroup for generating the trees. Bootstrap values out of 250
replicates are shown for branches involving mammals.
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Figure 4.18

Phylogenetic tree of DNMT3a.

Note: Chicken was the outgroup for generating the trees. Bootstrap values out of 250
replicates are shown for branches involving mammals.

Figure 4.19

Phylogenetic tree of DNMT3b.

Note: Chicken was the outgroup for generating the trees. Bootstrap values out of 250
replicates are shown for branches involving mammals.
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Figure 4.20

Phylogenetic tree of DNMT3L.

Note: Opossum was the outgroup for generating the trees. Bootstrap values out of 250
replicates are shown for branches involving mammals.

Figure 4.21

Multiple sequence alignment and functional domains of DNMT1.

Note: The species compared are opossum, rat, mouse, dog, bovine, macaque,
chimpanzee, and human, using Different color tags at the bottom represent conserved
domains. Black represents identical amino acids for that column in all the species. Gray
represent amino acids that differ. White indicates a gap.
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Figure 4.22

Multiple sequence alignment and functional domains of DNMT2

Note: The species compared are opossum, rat, mouse, dog, bovine, macaque,
chimpanzee, and human, using Different color tags at the bottom represent conserved
domains. Black represents identical amino acids for that column in all the species. Gray
represent amino acids that differ. White indicates a gap.

Figure 4.23

Multiple sequence alignment and functional domains of DNMT3a.

Note: The species compared are opossum, rat, mouse, dog, bovine, macaque,
chimpanzee, and human, using Different color tags at the bottom represent conserved
domains. Black represents identical amino acids for that column in all the species. Gray
represent amino acids that differ. White indicates a gap.
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Figure 4.24

Multiple sequence alignment and functional domains of DNMT3b.

Note: The species compared are opossum, rat, mouse, dog, bovine, macaque,
chimpanzee, and human, using Different color tags at the bottom represent conserved
domains. Black represents identical amino acids for that column in all the species. Gray
represent amino acids that differ. White indicates a gap.

Figure 4.25

Multiple sequence alignment and functional domains of DNMT3L.

Note: The species compared are opossum, rat, mouse, dog, bovine, macaque,
chimpanzee, and human, using Different color tags at the bottom represent conserved
domains. Black represents identical amino acids for that column in all the species. Gray
represent amino acids that differ. White indicates a gap.
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Real Time PCR for analysis of DNMT1, DNMT3a, and DNMT3b
mRNA abundance in bovine oocytes and embryos.

Note: Bars represent relative expression values of 2-cell embryos, 8-cell embryos, and
blastocysts to the expression in MII oocytes. Different letters represent statistically
significant differences (P<0.05).
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Table 4.1 Isoforms of the different DNMT’s from mouse, human and cow included
in the study
Enzyme
DNMT1

DNMT2

DNMT3a

DNMT3b

DNMT3L

Species

Chrom

Gene ID

mRNA

Protein

aa

Mouse

9 5.0 cM

13433

NM_010066.3

NP_034196.3

1619

Human

19p13.2

1786

NM_001379.1

NP_001370.1

1616

Cow

7q15

281119

NM_182651.1

NP_872592.1

1611

Mouse

2 A1

13434

NM_010067.2

NP_034197.2

415

Human

10p15.1

1787

NM_004412.3

NP_004403.1

391

Cow

13

353353

NM_181812.1

NP_861528.1

391

Mouse

12 A2-A3

13435

NM_007872.4

NP_031898.1

908

Human

2p23

1788

NM_022552.3

NP_072046.2

912

Cow

11

359716

XM_867643.2

XP_872736.1

909

Mouse

2 A2-A3

13436

NM_001003961.1 NP_001003961.1

859

Human

20q11.2

1789

NM_006892.3

NP_008823.1

853

Cow

13

31074162

AY244710

AAP20552.1

826

Mouse

10 C1

54427

NM_001081695.1 NP_001075164.1

421

Human

21q22.3

29947

NM_013369.2

NP_037501.2

387

Cow

1

613785

XM_864897.2

XP_869990.2

417

123

Table 4.2 Percent identity scores for DNMT methyltransferases in human, mouse
and cow.
DNMT1

DNMT2

DNMT3a DNMT3b DNMT3L

Human vs. Mouse

77%

75%

95%

81%

57%

Mouse vs. Cow

75%

76%

97%

75%

60%

Human vs. Cow

88%

85%

96%

84%

72%

Percent identity scores were obtained from Pairwise Sequence Alignments as the number
of identities in the alignment divided by the number of residues compared (gap positions
are excluded).

Table 4.3 DNA methyltransferase sequences used for phylogenetic trees.

Taxon

Database

Accession

Status

DNMT

DNMT1

DNMT2

Gallus gallus
Monodelphis domestica
Bos taurus
Homo sapiens
Pan troglodytes
Macaca mulatta
Mus musculus
Rattus norvegicus
Canis familiaris
Gallus gallus
Monodelphis domestica
Bos taurus
Homo sapiens
Pan troglodytes
Macaca mulatto
Mus musculus
Rattus norvegicus
Canis familaris

NCBI
NCBI
NCBI
NCBI
UCSD
NCBI
NCBI
NCBI
UCSD

NP_996835.1
NP_001028141.1
NP_872592.1
NP_001370.1
chr19.11.012.a
XP_001104704.1
NP_034196.3
NP_445806.1
chr20.54.038.a

NCBI
NCBI
NCBI
NCBI
NCBI
NCBI

NP_001020002.1
XP_001377353.1
NP_861528.1
NP_004403.1
XP_001151907.1
hmm234931

NCBI
NCBI
NCBI

NP_034197.2
NP_001026813.1
XP_848593.1

Refseq
Refseq
Refseq
Refseq
Predicted Build 2, v12
Predicted1,2
Refseq
Refseq
Predicted v 2.0 May 20052
Curated
Predicted
Refseq
Refseq
Predicted
Predicted ab initio Build 1.1
Refseq
Refseq
Predicted

Chicken was the outgroup for analysis except for DNMT3L, for which it was
opossum.
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Table 4.3 Continued
DNMT

DNMT3a

DNMT3b

DNMT3L

Taxon

Database

Accession

Status

Gallus gallus
Monodelphis domestica
Bos taurus
Homo sapiens
Pan troglodytes
Macaca mulatto
Mus musculus
Rattus norvegicus
Canis familaris
Gallus gallus
Monodelphis domestica
Bos taurus
Homo sapiens
Pan troglodytes
Macaca mulatta
Mus musculus
Rattus norvegicus
Canis familaris

NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI

NP_001020003.1
XP_001380132.1
XP_872736.1
NP_072046.2
XP_001148246.1
XP_001083234.1
NP_031898.1
NP_001003958.1
XP_540110.2
NP_001019999.1
XP_001362485.1
AAP20552.1
NP_008823.1
XP_514580.2
XP_001107249.1
NP_001003961.1
NP_001003959.1
hmm47423

Gallus gallus
Monodelphis domestica
Bos taurus
Homo sapiens
Pan troglodytes
Macaca mulatta
Mus musculus
Rattus norvegicus
Canis familaris

NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI
NCBI

NA
XP_001377724.1|
XP_869990.2
NP_037501.2
XP_525483.2
XP_001118368.1
NP_001075164.1
NP_001003964.1
XP_849972.1

Refseq
Predicted
Predicted
Refseq
Predicted
Predicted
Refseq
Refseq
Predicted
Refseq
Predicted
From mRNA
Refseq
Predicted
Predicted
Refseq
Refseq
Predicted ab initio Build
2.1
NA
Predicted
Predicted
Refseq
Predicted
Predicted
Refseq
Refseq
Predicted ab initio Build
2.1
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Table 4.4 Primer used for gene expression analysis by Real Time PCR

Genes

Primer sequences and positions (5’ - 3’)

DNMT1_F

AATGGGCAGATGTTCCATGC

(2356-2376)

DNMT1_R

CCTCCGTCGGCTGAGTTTT

(2653-2672)

DNMT3A_F CTGGCTCTTTGAGAATGTGGTG

(2372-2394)

DNMT3A_R TCACTTTGCTGAACTTGGCTATT

(2607-2630)

DNMT3B_F GGGAAGGAGTTTGGAATAGGAG

(698-720)

DNMT3B_R CTCTGGTTGCTTGTTGTTAGGTT

(1114-1137)

GAPDH_F

TGCTGGTGCTGAGTATGTGGT

(333-354)

GAPDH_R

AGTCTTCTGGGTGGCAGTGAT

(627-648)
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Fragment
size (bp)

Accession
Number

298

NM_182651.1

236

XM_867643

417

NM_181813

295

XM_865742

CHAPTER 5
CONCLUSIONS

Nuclear reprogramming after NT has been extensively reviewed over the past few
years (Rideout et al., 2001; Jaenisch, 2002; Mann and Bartolomei, 2002; Cezar, 2003;
Han et al., 2003b; Jouneau and Renard, 2003; Latham, 2005; Rodolfa and Eggan, 2006;
Eilertsen et al., 2007). These reviews and several studies have indicated that SCNT
extensively alters the gene expression of differentiated somatic cells to more closely
resemble that of embryonic nuclei. However, a combination of in vitro culture conditions,
aggressive manipulation and insufficient reprogramming, compromises the
developmental potential of SCNT embryos. Cloned embryos present different degrees of
aberrations in chromatin structure and DNA methylation, which cause inadequate
repression of developmental genes or the expression of unnecessary somatic genes. The
outcomes of SCNT are very variable, ranging from early embryonic death, lack of
implantation, abortions, perinatal deaths, up to the few cloned animals that have reached
adulthood with no evident pathologies. These variable outcomes could be the
manifestation of different degrees of nuclear reprogramming and have lead some authors
to suggest that nuclear reprogramming is a haphazard and stochastic phenomenon
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(Somers et al., 2006; Eilertsen et al., 2007; Niemann et al., 2008). Conversely a recent
study has suggested that the small mRNA differences in a selected panel of genes
indicate a uniform rather than random course of reprogramming (Cavaleri et al., 2008).
The variability in the phenotypes observed in clones derived from the same donor cell
line, makes it harder to establish a unique theory for nuclear reprogramming.
Microarray analysis has been used to explore the transcriptome profile of cloned
embryos relative to that of donor cells and IVF embryos. However, the appropriate
microarray platform is crucial in order to detect changes in particular genes. Microarray
developed from cDNA libraries should have a representation of embryonic genes to be
sensitive to changes in the expression of genes that are expressed exclusively during early
embryonic development. The Affymetrix GeneChip Bovine Genome Array is built from
cDNA libraries and predicted sequences to represent all tissues including early embryos
(see Appendix A). The lack of annotation for the bovine genome is still a limitation even
when an appropriate microarray platform is used. The fact the bovine genome annotation
is still an ongoing process generates inconsistency in annotations over time, which is one
of the biggest pitfalls in microarray data analysis (Noth and Benecke, 2005; PerezIratxeta and Andrade, 2005; Stalteri and Harrison, 2006).
Inconsistencies in microarray annotation should be carefully considered during
and after microarray data analysis. To minimize the impact of annotation inconsistencies
on Affymetrix microarray studies, the probe set identifiers and the annotation version
should be recorded along with gene titles and gene symbols. It could be stated that a
microarray data set can only be considered completely analyzed if the annotation for the
whole genes set is complete. Another constrain of microarray technology is the
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variability of results due to several factors including amplification and hybridization
efficiency, starting RNA quality, and expertise of the person performing the experiments.
Affymetrix microarrays have several amplification and hybridization controls that help
identify any failure during the process (see Appendix B).
To minimize variations due to RNA we started with similar amounts of total RNA
with comparable quality for all groups. A complete report from, each microarray
hybridization, was used to exclude samples that did not pass the quality control (see
Appendix C). All procedures were performed by the same person to prevent the inclusion
of more extraneous variation.
The present studies corroborate the extensive transcriptional reprogramming that
has been reported for cloned embryos using global gene expression analyses. Seven days
after nuclear transfer, the transcriptome profile of the cloned blastocysts has changed so
drastically that it no longer resembles that of the donor cells. The cloned embryos global
gene expression closely resembles that of blastocyst produced by fertilization. Based on
this finding alone, it could be suggested that nuclear reprogramming is complete.
However, the alterations in a small set of genes involved in DNA methylation and
chromatin remodeling, could cause epigenetic alterations downstream.
Nuclear reprogramming seems to be influenced by the genomic background of
donor somatic cells and their reprogramming potential. Increasing the ability of
chromatin to be reprogrammed by the oocyte has been attempted with Somatic Cell
Chromatin Transfer (Sullivan et al., 2004). When somatic cells are exposed to cellular
extracts from mitotic cells prior to transfer, their chromosomes are condensed and
somatic nuclear factors are removed. Although the overall cloning efficiency does not
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seem to be affected by SCCT, a trend toward enhanced survival of cloned calves after
one month postpartum has been observed. However, a global gene expression study that
included both NT and CT embryos found no difference in their gene expression pattern
by the blastocyst stage (Zhou et al., 2007). These results could suggest that the
condensation of the somatic chromatin prior to nuclear transfer has no effects on
transcriptional reprogramming.
Studies on the effect of serial cloning on nuclear reprogramming have produced
conflicting results. Some authors have suggested that consecutive rounds of cloning
produce cell rejuvenation (Hill et al., 2000; Hill et al., 2001; Liu et al., 2001; Kuroiwa et
al., 2004) and increase the reprogramming potential of somatic cells (Cho et al., 2007).
Conversely, other reports suggest that epigenetic errors could accumulate as a result of
serial cloning and prolonged in vitro culture decreasing cloning efficiency (Wakayama et
al., 2000; Peura et al., 2001; Kubota et al., 2004). The present studies show that serial
cloning does not significantly affect transcriptional reprogramming of cloned blastocysts.
The global transcriptome profile of blastocysts from four consecutive rounds of cloning
did not significantly differ from the one obtained from blastocysts after only one round of
cloning. However, for a set of genes, misregulation was more marked in the blastocysts
obtained from four rounds of cloning (see Appendixes D and E).
When the transcript abundance of four selected genes was analyzed in fetal
fibroblasts isolated from 70-day old fetuses, obtained from successive rounds of cloning,
no conclusive results could be obtained. These findings could suggest that misregulations
in the expression of some genes could be completely reprogrammed in clones that
survive beyond the early stages of development. However, alterations in the transcription
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of other genes could persist throughout fetal development and only become manifest after
birth. In fact, genes that were altered in cloned blastocyst, were also misregulated in the
organs of clones that died shortly after birth (Li et al., 2005).
Multiple studies have pointed to alterations in DNA methylation in cloned
embryos, particularly a genome-wide hypermethylation (Kang et al., 2001; Han et al.,
2003b; Beaujean et al., 2004). Global demethylation soon after fertilization appears to be
a prerequisite for successful reprogramming later in embryonic development, and
possibly for successful SCNT outcomes. The results of the present study indicate that
both de novo DNA methyltransferases are being transcribed at a significantly higher rate
in the cloned embryos. Surprisingly alterations in DNA methylation do not seem to be
life threatening for the cloned embryos, although extensive aberrations may be fatal.
Epigenetic alterations can result in different phenotypic manifestations in each embryo,
which would account for the variable outcomes of SCNT. The traditional view has
maintained that DNA methylation is the primary epigenetic mark responsible for
repressive chromatin structure. According to this theory, DNA methylation attracts
methylated cytosine binding proteins, which in turn recruit repressor complexes and
histone deacetylases to further silence chromatin. An alternative model suggests that it is
chromatin structure which determines the DNA methylation or demethylation (Szyf,
2005a). The precise sequence of events leading to gene silencing would determine the
right approach for improving reprogramming after SCNT.
Species-specific differences in DNA methylation reprogramming have been
suggested, although the overall process appears to be conserved among the clones of
different species. Aberrations in genome-wide reprogramming have been reported for
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mouse, rat, pig, and bovine NT embryos (Bourc'his et al., 2001; Dean et al., 2001) . We
analyzed the structural and functional conservation of DNA methyltransferases during
preimplantation embryo development in mouse, human and cow by multiple sequence
alignment, phylogenetic analysis, and study of conserved domains. We observed a closer
homology between human and cow proteins with the exception of DNMT3b. The
available DNMT3b sequence (AAP20552.1) lacked several amino acids in the C-terminal
domain, which were present in all other mammalian species analyzed. After annotation
and correction, cow and human DNMT3b sequences showed a higher degree of
homology. These findings have corroborated the closer phylogenetic relationship
between human and bovine de novo methylation genes, which could suggest that the
bovine model would be more appropriate for studying DNA methylation during
embryogenesis. The corrected sequence was submitted to the Bovine Genome Annotation
Submission site (see Appendix F). Additionally, we analyzed the changes in mRNA
abundance of DNMT1, DNMT3a and DNMT3b in oocytes and preimplantation embryos
to determine the moment in which these transcripts are higher in the embryos. As
expected, DNMT1 was low throughout early embryo development. Consistent with our
microarray analyses, DNMT3a transcript abundance was higher in IVF derived
blastocysts compared to DNMT3b, which could indicate an earlier role of DNMT3a in de
novo DNA methylation during early embryogenesis.
Chromatin associated proteins play a key role in nuclear remodeling. In the
present studies HMGN3 was significantly higher in IVF derived blastocysts compared to
blastocysts produced by CT. The levels of HMGN3 transcript in CT embryos resembled
the ones detected in somatic cells. Although the exact function of HMGN3 during early
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embryonic development has not been determined, its role in facilitating chromatin
modifications and enhancing transcription, replication, and DNA repair is critical for
early embryo development (West et al., 2001).
Reprogramming of DNA methylation and histone modifications to ensure a
pattern of gene expression compatible with embryonic development is essential for
successful cloning. Identification of the specific factors present in the ooplasm, which are
necessary for epigenetic reprogramming, will provide a better understanding of the
underlying mechanisms and would improve cloning efficiency. Although several
questions regarding the low efficiency of SCNT still remain unanswered, the central role
of nuclear reprogramming on the outcome of cloning is evident. Increasing the efficiency
of SCNT would have a great impact on biomedical sciences and agriculture, particularly
therapeutic cloning, and the production of animals with desired qualities. Understanding
the reprogramming process of SCNT derived embryos would be instrumental to increase
the success rate of cloning. Several strategies have been used to determine the extent of
nuclear reprogramming in cloned embryos.
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GeneChip Bovine Genome Array Specifications
GeneChip probe sets

24,072

Bovine transcripts

approximately 23,000

UniGene clusters

approximately 19,000

Array format

100

Feature size

11 μm

Oligonucleotide probe length

25-mer

Probe pairs/sequence

11

Hybridization controls:

bioB, bioC, bioD, from E. coli
cre from P1 B. subtilis

Poly-A controls:

dap, lys, phe, thr, trp from B. subtilis

Housekeeping/Control genes:

actin, GAPDH, eflα, 5.8S rRNA, 12S rRNA, 18S
rRNA, cyclophilin B, glutathione S-transferase,
lactophorin, translation initiation factor eIF-4E

Detection sensitivity

1:100,00011

Critical Specifications
1
As measured by detection in comparative analysis between a complex target containing
spiked control transcriptions and a complex target with no spikes
The design of the array is based on content from Bovine UniGene Build 57 (March 24,
2004) and GenBank® mRNAs.
The gene annotation used for the present dissertation was the November 2007 update.
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Origin of control

Control Gene Name

Type of controls

lys
B. subtilis

phe

Poly-A-tailed sense RNAs used as controls for the

thr

labeling and hybridization process.

dap

They are also used to estimate assay sensitivity.

bioB
E. coli

bioC
bioD

P1 Bacteriophage

cre

synthetic

B2 Oligo

Antisense biotinylated cRNAs used as
hybridization controls.
Grid alignment.
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APPENDIX C
HYBRIDIZATION PERFORMANCE OF MICROARRAYS
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Sample
IVF1
IVF2
IVF3
CT1-1
CT1-2*
CT1-3
CT1-4*
CT4-1
CT4-2*

165

CT4-3
CT4-4
DC1-1
DC1-2
DC1-3
DC4-1
DC4-2
DC4-3

Backgr
47.3
70.0
57.0
60.8
54.2
67.5
54.7
55.8
56.0
59.8
55.1
47.4
38.7
54.2
46.5
66.1
71.4

Scale
factor
3.443
4.994
5.966
7.606
45.634
5.059
41.442
4.877
36.20
3.31
3.44
2.337
2.246
1.665
2.350
1.549
1.526

Noise
1.63
2.40
2.00
2.13
1.92
2.33
1.96
2.01
1.94
2.09
1.93
1.68
1.39
1.94
1.59
2.31
2.50

Present
48.30%
41.50%
42.70%
39.00%
9.50%
43.50%
18.60%
43.60%
23.30%
49.00%
48.10%
55.30%
59.10%
56.70%
55.40%
54.30%
55.30%

Average
Signal (P)
1579.0
1896.3
1957.0
2076.5
5806.5
1776.8
3801.2
1849.0
3557.6
1515.8
1595.4
1282.8
1196.8
1240.0
1287.1
1294.1
1266.8

Average
Signal (A)
25.1
58.9
51.1
70.2
417.8
48.0
264.7
38.6
178.6
30.6
37.7
28.5
22.2
28.9
27.1
30.7
27.7

*Samples excluded from the microarray analysis
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Actin-5'
44.6
112.7
37.5
24.7
1359.9
69.7
483.4
7.7
330.4
50.9
44.3
57.7
63.6
26.7
35.8
44.2
37.8

Actin-3'
583.8
491.9
295.1
233.4
5460.2
347.3
85.3
349.6
878.1
266.1
316.3
584.3
395.6
678.1
540.8
514.3
500.5

Actin
3'/5'ratio
13.1
4.4
7.9
9.4
4.0
5.0
0.2
45.4
2.7
5.2
7.1
10.1
6.2
25.4
15.1
11.6
13.2

Gapd-5'
1152.9
1560.5
1328.3
2723.5
82.8
1103.2
430.1
1748.0
208.7
1009.5
5432.1
2108.0
9686.6
8504.9
1826.4
20518.6
6592.7

Gapd-3'
6351.9
10485.9
20239.5
17147.8
7979.5
17142.8
10201.7
18766.2
9698
12757.2
21479.1
22469.9
20649.8
7019.6
23085.8
18656.5
18854.6

GAPDH
ratio 3'/5'
5.5
6.7
15.2
6.3
96.4
15.5
23.7
10.7
46.5
12.6
4.0
10.7
2.1
0.8
12.6
0.9
2.9
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Probe Set ID
Bt.5154.1.S1_at

Gene Title
heat shock 70 kD protein 1 /// heat shock 70 kD protein 2

Gene Symbol
HSPA1A

IVF
16655.53

NT1
4021.00

NT4
2975.26

Fold
change
IVF/NT1
4.14

Bt.9759.1.S1_a_at

neuroguidin, EIF4E binding protein

NGDN

11691.84

5346.60

3041.70

2.19

3.84

Bt.5039.1.S1_at

high mobility group nucleosomal binding domain 3

HMGN3

11195.32

6522.85

4078.53

1.72

2.74

Bt.9759.2.S1_at

neuroguidin, EIF4E binding protein

NGDN

5999.87

2431.02

1665.35

2.47

3.60

Bt.4737.1.S2_s_at

prion protein

PRNP

3552.73

1614.40

1425.30

2.20

2.49

Bt.1854.1.S1_at

intraflagellar transport protein 20

IFT20

3526.47

2139.25

1380.10

1.65

2.56

Bt.27874.1.S1_s_at

phosphatidylserine receptor

PTDSR

3476.73

1517.25

980.58

2.29

3.55

Bt.15787.1.S1_at
Bt.20204.1.S1_at

Bcl-2 inhibitor of transcription

BIT1

2989.58

2007.15

1415.27

1.49

2.11

Sjogren's syndrome/scleroderma autoantigen 1

SSSCA1

1695.08

1056.05

579.62

1.61

2.92

Bt.4595.1.S1_at

TSR2, 20S rRNA accumulation, homolog (S. cerevisiae)

TSR2

1567.39

755.35

568.11

2.08

2.76

Bt.12250.1.S1_at

C14orf10

1525.13

981.80

567.59

1.55

2.69

CARF

1390.25

907.40

668.85

1.53

2.08

Bt.13928.2.S1_a_at

chromosome 14 open reading frame 10
collaborates/cooperates with ARF (alternate reading frame)
protein
sodium channel modifier 1

SCNM1

786.05

390.50

249.35

2.01

3.15

Bt.6620.1.S1_at

myosin, heavy polypeptide 7, cardiac muscle, beta

MYH7

673.53

219.15

135.85

3.07

4.96

Bt.19972.1.S1_at

proton-dependent gastrointestinal peptide transporter

PEPT1

567.85

189.46

170.27

3.00

3.34

Bt.28010.1.S1_at

protease inhibitor 3, skin-derived (SKALP)

PI3

510.98

91.50

56.05

5.58

9.12

Bt.5126.1.S1_at

hypertension-related calcium-regulated gene

COMMD5

449.40

335.50

176.24

1.34

2.55

Bt.22523.1.S1_at

dispatched homolog 1 (Drosophila)

DISP1

402.17

174.75

155.13

2.30

2.59

Bt.5828.1.S1_at

SERTA domain containing 1
transition protein 1 (during histone to protamine
replacement)
microtubule-associated protein, RP/EB family, member 2

SERTAD1

357.71

287.95

157.44

1.24

2.27

TNP1

233.38

155.00

98.93

1.51

2.36

MAPRE2

199.89

183.45

69.82

1.09

2.86

oviduct specific glycoprotein
neurofilament, medium polypeptide

OVGP1

196.48

168.70

78.09

1.16

2.52

NEF3

188.69

126.35

46.89

1.49

4.02

Bt.27095.1.S1_at

Bt.333.1.S1_at
Bt.14098.1.S1_at
Bt.4158.1.A1_at
Bt.22856.1.S1_at
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Fold
change
IVF/NT4
5.60

Bt.9807.1.S1_at

glycoprotein (transmembrane) nmb

GPNMB

154.95

52.30

24.03

2.96

6.45

Bt.23151.1.S1_at

FUT10

154.43

114.10

55.12

1.35

2.80

SLC6A3

149.32

48.30

21.24

3.09

7.03

Bt.12739.2.S1_a_at

fucosyltransferase 10 (alpha (1,3) fucosyltransferase)
solute carrier family 6 (neurotransmitter transporter,
dopamine), member 3
membrane-associated ring finger (C3HC4) 2

C3HC4

110.18

51.40

23.87

2.14

4.62

Bt.6556.1.S1_at

regakine-1 protein

LOC504773

89.66

25.75

39.07

3.48

2.29

Bt.12080.2.S1_at

Bernardinelli-Seip congenital lipodystrophy 2

BSCL2

88.59

38.70

13.83

2.29

6.41

Bt.13036.1.S1_at

progesterone receptor

PGR

79.73

4.69

36.57

17.02

2.18

Bt.2157.1.S1_a_at

RPGR-interacting protein 1

RPGRIP1

77.03

58.90

6.56

1.31

11.75

Bt.28409.2.S1_at

DNA replication factor

CDT1

71.69

55.20

12.73

1.30

5.63

Bt.3771.1.A1_at
Bt.27752.1.S1_at

Nucleolar protein family A, member 1

NOLA1

69.73

21.50

21.26

3.24

3.28

tensin 4

TNS4

69.66

43.05

8.73

1.62

7.98

Bt.13024.2.S1_at

purinergic receptor P2Y G-protein coupled, 2

P2RY2

67.08

46.15

22.11

1.45

3.03

Bt.28017.1.S1_at

vacuolar H+-ATPase

LOC407191

65.07

34.20

17.47

1.90

3.73

Bt.512.1.S1_at

nucleotide phosphodiesterase, 3'-5'-cyclic

PDE1A

60.70

15.59

15.85

3.89

3.83

Bt.12928.1.S1_at

Interleukin 13

IL13

58.85

37.70

9.25

1.56

6.36

Bt.29129.1.S1_at

anterior gradient 2 homologue

agr2

45.07

39.00

21.29

1.16

2.12

Bt.7239.1.S1_at
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Probe Set ID

NDUFS2

Bt.3583.1.S1_at

Gene Title
NADH dehydrogenase (ubiquinone) Fe-S protein 2,
49kDa (NADH-coenzyme Q reductase)
villin 2

Bt.663.1.S1_at

NT4

6724.02

13373.15

14960.42

1.99

2.22

VIL2

6698.24

13698.40

17209.52

2.05

2.57

palladin, cytoskeletal associated protein

PALLD

5038.25

14502.45

19368.34

2.88

3.84

Bt.9068.1.S1_at

non-muscle myosin heavy chain

LOC404108

3,972.71

6,504.05

8,152.57

1.64

2.05

Bt.2841.1.S1_at

tryptophanyl-tRNA synthetase
guanidine nucleotide binding protein, (G protein), alpha
inhibiting activity polypeptide 2
golgi autoantigen, golgin subfamily a, 7

WARS

2,665.06

4,276.85

5,569.16

1.60

2.09

GNAI2

2,389.08

3,859.15

7,740.86

1.62

3.24

GOLGA7

1,689.70

2,728.90

4,288.07

1.62

2.54

zinc finger protein 313

Znf313

1,523.55

2,140.45

3,126.63

1.40

2.05

Bt.803.1.A1_at

chromatin modifying protein 1B

CHMP1B

1,315.99

2,093.75

3,934.13

1.59

2.99

Bt.4503.1.S1_at

mitochondrial carrier homolog 2

Mtch2

1,279.84

3,359.75

4,555.63

2.63

3.56

Bt.23603.3.S1_at

F-box protein 9

FBXO9

1,058.76

1,948.25

2,813.78

1.84

2.66

Bt.7169.1.S1_at

methylmalonyl Coenzyme A mutase

MUT

898.23

1,622.10

1,943.02

1.81

2.16

Bt.14010.1.S1_at

leukotriene B4 12-hydroxydehydrogenase

LTB4DH

841.63

5688.55

11345.50

6.76

13.48

Bt.8933.1.S1_at

adaptor-related protein complex 3, sigma 2 subunit

AP3S2

667.54

1,071.50

1,425.67

1.61

2.14

Bt.12261.1.A1_at

taspase 1

C20orf13

435.56

1,113.20

1,293.73

2.56

2.97

Bt.4738.1.S1_at

calpastatin

CAST

329.41

504.45

890.74

1.53

2.70

Bt.26764.1.A1_at

Lectomedin 2

LEC2

307.46

1,085.70

1,567.79

3.53

5.10

Bt.1388.1.S1_at

Abl-philin 2 isoform 2

ZDHHC16

286.19

630.40

948.26

2.20

3.31

Bt.4311.1.S1_at
Bt.962.1.S1_at
Bt.760.1.S1_at

IVF

Fold
change
NT4/IVF

NT1

Bt.4475.1.S1_at

Gene Symbol

Fold
change
NT1/IVF
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Bt.20236.1.S1_at

thrombospondin repeat containing 1

ADAMTSL4

211.65

322.35

522.48

1.52

2.47

Bt.5330.1.S1_at

lysosomal-associated membrane protein 1

LAMP1

194.91

174.90

1,195.48

0.90

6.13

Bt.8870.3.S1_at

CGI-119 protein

CGI-119

128.16

218.35

403.76

1.70

3.15

Bt.23209.1.S1_a_at

lectomedin 2
adrenergic, beta 3, receptor

LEC2

83.06

279.90

418.46

3.37

5.04

ADRB3

26.17

52.65

89.07

2.01

3.40

Bt.318.1.S1_at
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Bt.4057.1.S1_at

myosin, heavy polypeptide 10, non-muscle

MYH10

21.07

38.95

83.71

1.85

3.97

Bt.4560.1.S1_s_at

trophoblast Kunitz domain protein 1

TKDP1

21.03

43.25

88.08

2.06

4.19

Bt.22858.1.S1_at

uroplakin IIIB

UPK3B

16.02

16.70

100.71

1.04

6.29

Bt.12304.1.S1_at

interferon-stimulated protein, 15 kDa

ISG15

15.51

67.95

66.46

4.38

4.29

Bt.26830.2.S1_a_at

5,10-methylenetetrahydrofolate reductase (NADPH)

MTHFR

12.02

57.85

79.11

4.81

6.58

Bt.5101.1.S1_at

PRNPIP

8.97

32.00

74.73

3.57

8.33

GNAS1

8.03

42.00

44.87

5.23

5.59

ZNF325

3.81

22.10

121.65

5.80

31.93

GNAS1

8.03

42.00

44.87

5.23

5.59

Bt.12304.1.S1_at

prion protein interacting protein
Guanine nucleotide binding protein (G protein), alpha
stimulating activity polypeptide 1
Zinc finger protein 325 (gonadotropin inducible
transcription repressor-3)
Guanine nucleotide binding protein (G protein), alpha
stimulating activity polypeptide 1
interferon-stimulated protein, 15 kDa

15.51

67.95

66.46

4.38

4.29

Bt.12261.1.A1_at

taspase 1

C20orf13

435.56

1113.20

1293.73

2.56

2.97

Bt.3583.1.S1_at

villin 2

VIL2

6698.24

13698.40

17209.52

2.05

2.57

Bt.17862.1.A1_at
Bt.2301.1.S1_at
Bt.17862.1.A1_at
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Gene
symbol

Glean

Landmark

ANP32A

GLEAN_11459

Chr10.20:24030..29969

AQP8

GLEAN_04832

Chr25.32:1581000..1655000

DNMT3L

GLEAN_15626

Chr1.170:55000..70000

DNMT2

GLEAN_20779

Chr13.27:1109000..1145000

Start

End

Strand

Gene ID

Predited
mRNA

Predicted
Protein

21549

29170

-

1420670

1588474

-

450206

XM_583253.3

XP_583253.3

56219

70607

-

613785

XM_864897

XP_869990

1110166

1163352

-

353353

NM_181812.1

NP_861528.1
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DNMT3B

GLEAN_08037

Chr13.65:734000..758000

393306

756255

+

353354

NM_181813

NP_861529.1

BCL2L

GLEAN_10559

Chr13.67:376000..428000

377692

426902

-

282152

NM_001077486.2

NP_001070954.1

BMP6

GLEAN_00235

Chr23.57:1110000..1162213

1113316

1161213

-

617566

XM_869844.2

XP_874937.2

BMP8B

GLEAN_02029

Chr14.89:150000..180000

159588

175685

+

EED

Chr29.14:470000..504000

471825

502151

-

404183

NM_001040494.1

NP_001035584.1|

EGF

GLEAN_06204
GLEAN_06456 +
GLEAN_06457

Chr6.13:889000..995000

916453

993377

-

530315

XM_001253862

XP_001253863.1

GATA3

GLEAN_15109

Chr13.15:381000..402000

382644

400398

-

505169

NM_001076804.1

NP_001070272.1

GATA6

GLEAN_00216

Chr24.45:782000..813000

782580

811772

+

HMGN3A

GLEAN_08006

Chr9.20:2024000..2060000

-

515652

NM_001034504.1

NP_001029676.1

IFITM3

GLEAN_22223

Chr29.68:19000..21500

NP_863657.1

MBD3

GLEAN_09279

Chr7.60:7000..13000

MECP2

GLEAN_23979

ChrX.59:114000..163000

2024869

2059808

20015

20932

+

282255

NM_181867.1

4124

11374

+

616090

XM_868057

114897

161821

+

539629

XM_588477.3

XP_588477.3

NOTCH3

GLEAN_12973

Chr7.14:120000..165000

121620

160252

-

PLAC1

GLEAN_25707

ChrUn.104:462000..465000

463224

463763

-

767997

NM_001077057.1

NP_001070525.1

PLAC8

GLEAN_20429

Chr6.101:1137000..1208000

1138588

1148466

+

509228

NM_001025325.1

NP_001020496.1

SMARCA1

GLEAN_09261

ChrX.27:647000..703000

643271

714992

+

535439

XR_028639.1

STAT1

GLEAN_20786

Chr2.93:762000..968000

763383

900710

-

510814

XM_001253473.1

XP_001253474.1

STAT4

GLEAN_17376

Chr19.41:140000..198000

165609

196381

-

282086

SMARCAL1

GLEAN_20241

Chr2.124:232000..285000

233017

345663

-

338072

NM_176666.1

NP_788839.1

173

XR_028762.1

